Criticalkare Pharma

Strength	250 mg
Packaging Type	Box
Volume	5 ml
Packing	1 PFS Of 5ml
Physical Form	Solution
Brand	Fulveser
Treatment	Hormone Receptor Positive Breast Cancer
Application	It should only be administered by a trained doctor or nurse as a slow intramuscular injection. Do no
Manufactured By	SAMARTH LIFE SCIENCES PVT LTD
Country of Origin	Made in India

Fulveser 250mg injection contains the active substance fulvestrant. It is an antineoplastic drug that belongs to the class estrogen receptor antagonist. Estrogen, a type of female sex hormone, can sometimes be involved in the growth of breast cancer. This medicine is used alone to treat postmenopausal women with a certain type of breast cancer called estrogen receptor-positive breast cancer that is locally advanced or spread to other parts of the body. It is also indicated in combination with other anti-cancer medication to treat women with certain types of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, which is locally advanced or spread to other parts of the body. 

Do not take this injection if you are allergic to fulvestrant or any other ingredients of this medicine, pregnant or breastfeeding, or have severe liver problems. Before initiating the treatment, inform your physician if you have kidney or liver problems, bone diseases, bleeding disorders, and heart diseases. Fulveser 250mg injection is not indicated in children and adolescents under 18 years. Report to your physician if you have allergic reactions, including swelling of the face, lips, tongue, or throat, after administering this injection. 

Uses

• Treat Hormone receptor (HR)-positive, human epidermal growth receptor 2 (HER2)-negative breast cancer in postmenopausal women.

More Information

• Store Fulveser 250mg injection in the refrigerator (2°C to 8°C)
• Do not freeze
• keep the injection away from the reach of children and pets.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.

Safety Advices Pregnancy  

Fulveser 250mg injection is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 2 years after your last dose is necessary.    

Breast Feeding  

Breastfeeding is not recommended in patients taking Fulveser 250mg injection because the medicine passes into the breast milk in small amounts and may harm your baby.  

Lungs  

It is unknown whether Fulveser 250mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Fulveser 250mg injection is unsafe when administered in patients with severe liver diseases. Dose adjustments are necessary in moderate liver failure. Inform your physician if you have liver problems before initiating the therapy.    

Alcohol  

Consuming alcohol may affect the effectiveness of the Fulveser 250mg injection. Stop consuming alcohol if you are taking this medicine.   

Driving  

Fulveser 250mg injection does not affect the ability to drive. Please consult your doctor for more advice.

Side Effects

• Constipation, diarrhea
• Loss of appetite
• Nausea, vomiting
• Decreased RBC, WBC, and Platelets
• Infections
• Joint and muscle pain
• Backache, bone pain
• Weakness, tiredness
• Headache
• Cough, difficulty breathing
• Hot flushes
• Pain at the site of injection

• Changes in heart rhythm
• Severe neutropenia(decreased WBC)
• Liver failure, inflammation of liver
• Hypersensitivity reaction
• Swelling in the body

Strength	250 mg
Packaging Type	Box
Volume	5 ml
Packing	2 PFS Of 5ml
Physical Form	Solution
Brand	Fulvetraz
Treatment	Advanced Breast Cancer
Application	It should only be administered by a trained doctor or nurse as a slow intramuscular injection. Do no
Manufactured By	ALKEM LABORATORIES LTD
Country of Origin	Made in India

Fulvetraz 250mg injection contains the active substance fulvestrant. It is an antineoplastic drug that belongs to the class estrogen receptor antagonist. Estrogen, a type of female sex hormone, can sometimes be involved in the growth of breast cancer. This medicine is used alone to treat postmenopausal women with a certain type of breast cancer called estrogen receptor-positive breast cancer that is locally advanced or spread to other parts of the body. It is also indicated in combination with other anti-cancer medication to treat women with certain types of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, which is locally advanced or spread to other parts of the body. 

Do not take this injection if you are allergic to fulvestrant or any other ingredients of this medicine, pregnant or breastfeeding, or have severe liver problems. Before initiating the treatment, inform your physician if you have kidney or liver problems, bone diseases, bleeding disorders, and heart diseases. Fulvetraz 250mg injection is not indicated in children and adolescents under 18 years. Report to your physician if you have allergic reactions, including swelling of the face, lips, tongue, or throat, after administering this injection.

Uses

• Treat Hormone receptor (HR)-positive, human epidermal growth receptor 2 (HER2)-negative breast cancer in postmenopausal women.

More Information

• Store Fulvetraz 250mg injection in the refrigerator (2°C to 8°C)
• Do not freeze
• keep the injection away from the reach of children and pets.
• If you have missed any dosing appointments, inform your doctor and schedule immediately. 

Safety Advices  Pregnancy  

Fulvetraz 250mg injection is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 2 years after your last dose is necessary.    

Breast Feeding  

Breastfeeding is not recommended in patients taking Fulvetraz 250mg injection because the medicine passes into the breast milk in small amounts and may harm your baby.  

Lungs  

It is unknown whether Fulvetraz 250mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Fulvetraz 250mg injection is unsafe when administered in patients with severe liver diseases. Dose adjustments are necessary in moderate liver failure. Inform your physician if you have liver problems before initiating the therapy.    

Alcohol  

Consuming alcohol may affect the effectiveness of the Fulvetraz 250mg injection. Stop consuming alcohol if you are taking this medicine.   

Driving  

Fulvetraz 250mg injection does not affect the ability to drive. Please consult your doctor for more advice.

Side Effects

• Constipation, diarrhea
• Loss of appetite
• Nausea, vomiting
• Decreased RBC, WBC, and Platelets
• Infections
• Joint and muscle pain
• Backache, bone pain
• Weakness, tiredness
• Headache
• Cough, difficulty breathing
• Hot flushes
• Pain at the site of injection

• Changes in heart rhythm
• Severe neutropenia(decreased WBC)
• Liver failure, inflammation of liver
• Hypersensitivity reaction
• Swelling in the body

Strength	250 mg
Packaging Type	Box
Volume	5 ml
Packing	2 PFS
Physical Form	Solution
Brand	V-Strant
Treatment	Advanced Breast Cancer
Application	It should only be administered by a trained doctor or nurse as a slow intramuscular injection. Do no
Manufactured By	BDR PHARMACEUTICALS INTERNATIONALS PVT LTD
Country of Origin	Made in India

V-Strant 250mg injection contains the active substance fulvestrant. It is an antineoplastic drug that belongs to the class estrogen receptor antagonist. Estrogen, a type of female sex hormone, can sometimes be involved in the growth of breast cancer. This medicine is used alone to treat postmenopausal women with a certain type of breast cancer called estrogen receptor-positive breast cancer that is locally advanced or spread to other parts of the body. It is also indicated in combination with other anti-cancer medication to treat women with certain types of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, which is locally advanced or spread to other parts of the body. 

Do not take this injection if you are allergic to fulvestrant or any other ingredients of this medicine, pregnant or breastfeeding, or have severe liver problems. Before initiating the treatment, inform your physician if you have kidney or liver problems, bone diseases, bleeding disorders, and heart diseases. V-Strant 250mg injection is not indicated in children and adolescents under 18 years. Report to your physician if you have allergic reactions, including swelling of the face, lips, tongue, or throat, after administering this injection.

Uses

• Treat Hormone receptor (HR)-positive, human epidermal growth receptor 2 (HER2)-negative breast cancer in postmenopausal women.

More Information

• Store V-Strant 250mg injection in the refrigerator (2°C to 8°C)
• Do not freeze
• keep the injection away from the reach of children and pets.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.

Safety Advices Pregnancy  

V-Strant 250mg injection is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 2 years after your last dose is necessary.    

Breast Feeding  

Breastfeeding is not recommended in patients taking V-Strant 250mg injection because the medicine passes into the breast milk in small amounts and may harm your baby.  

Lungs  

It is unknown whether V-Strant 250mg injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

V-Strant 250mg injection is unsafe when administered in patients with severe liver diseases. Dose adjustments are necessary in moderate liver failure. Inform your physician if you have liver problems before initiating the therapy.    

Alcohol  

Consuming alcohol may affect the effectiveness of the V-Strant 250mg injection. Stop consuming alcohol if you are taking this medicine.   

Driving  

V-Strant 250mg injection does not affect the ability to drive. Please consult your doctor for more advice.

Side Effects

• Constipation, diarrhea
• Loss of appetite
• Nausea, vomiting
• Decreased RBC, WBC, and Platelets
• Infections
• Joint and muscle pain
• Backache, bone pain
• Weakness, tiredness
• Headache
• Cough, difficulty breathing
• Hot flushes
• Pain at the site of injection

• Changes in heart rhythm
• Severe neutropenia(decreased WBC)
• Liver failure, inflammation of liver
• Hypersensitivity reaction
• Swelling in the body

Strength	100 mg
Brand	Lynparza
Tablets per Pack	56 Tablets
Usage	Ovarian Cancer, Breast Cancer, Pancreatic Cancer, Cancer Care
Form	Tablet
Pack Type	Strip
Maufacturer	ASTRAZENECA

Lynparza 100mg Tablet is an anticancer drug belonging to the category of poly adenosinediphosphate-ribose polymerase (PARP) inhibitor, containing the active ingredientOlaparib. It is used to treat ovarian, breast, pancreatic, and prostate cancer. Cancer is adisease in which cells multiply uncontrollably and abnormally. This medication can begiven alone or in combination with other anticancer medications.Speak with your doctor immediately if you experience breathlessness, chest pain, rapidheart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood testsbefore and every month during the treatment, as this medicine could reduce the counts ofRBC, WBC, and platelets. Tell your healthcare provider before starting treatment, if youhave been diagnosed with problems in your lungs, liver, heart, or kidneys.This drug is not recommended during pregnancy as it might harm the unborn baby andlead to miscarriage. Hence, it is advisable to do a pregnancy test before starting thistreatment for women of childbearing age. Ideally, it is better to continue birth controlmethods for a minimum of 6 months after completion of the treatment. Avoid breastfeedingyour baby while you are on the treatment, as it is unknown whether Lynparza 100mgTablet passes into the breast milk.

Lynparza 100mg Tablet is used to treat,• Ovarian cancer• Breast cancer• Prostate cancer• Pancreatic cancer

Storage
Store Lynparza 100mg Tablet in the original package at room temperature (20°C to 25°C).Keep it out of reach from children.

Side Effects
• diarrhea• nausea• vomiting• loss of appetite• weakness• red or sore mouth• increased liver enzymes• itchy or cracked skin• dry mouth• red or itchy eyes• nail problems• hair loss• fever• blood in the urine and a burning sensation while urinating

Strength	10 mg
Brand	Fludabine
Form	Tablet
Manufacturer	United Biotech Pvt Ltd
Packaging Type	Stripe
Storage Condition	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Prescription/Non prescription	Prescription
Usage / Application	Personal
Shelf Life	24 Months

Fludabine 10mg Injection is a chemotherapy medication containing the active ingredient fludarabine. It is used to treat B-cell chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia is cancer of white blood cells (disease-fighting agents) in which the body produces many abnormal white blood cells, and lymph nodes start to grow in various parts of the body. This can lead to organ failure, decrease in red blood cells, severe bleeding and infections.Fludabine 10mg Injection is not recommended for adolescents and children under 18 years of age, breastfeeding patients, and patients with severe kidney problems or low red blood cell count. Use effective birth control methods during the treatment with this medicine and for at least six months from the last dose. Avoid live vaccination while taking this medicine. Report to your doctor if you experience any allergic reactions while taking Fludabine 10mg Injection.Uses Treatment of B-Cell chronic lymphocytic leukemia (blood cancer)More Information Keep Fludabine 10mg Injection out of sight and reach of children.Store in a refrigerator (2°C to 8°C).Safety Advices Pregnancy  Fludabine 10mg Injection is not recommended for use in pregnancy. Your doctor will prescribe the medication if the benefits outweigh the risks.  Breast Feeding  Breastfeeding is not recommended during treatment with Fludabine 10mg Injection. Consult your doctor for advice  Lungs  Talk to your doctor if you have any lung conditions before starting treatment with Fludabine 10mg Injection.   Liver  It is essential to inform your doctor if you have any liver disorders before taking this medicine.  Alcohol  Consult your doctor regarding advice on alcohol consumption before starting treatment with Fludabine 10mg Injection.   Driving  Fludabine 10mg Injection may cause tiredness or disturbed vision. Avoid driving if you are unwell.Side Effects Lung infection (cough, chest pain, difficulty breathing)Unusual bleeding or bruisingBlood in urine, reduced amount of urine, or pain in your sideSkin reactions (redness, inflammation, or blistering)PalpitationsDiarrheaFeverWeakness, tirednessNausea, vomitingLow blood countInfections

Daily Dose Strength	140mg
Brand	Ibrunat
Strength	140 mg
Pack Size	30 Capsules
Indication	CLL
Form	Capsule
Storage Condition	Store the capsules in the original packaging at room temperature (20-25 DegreeC).
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Ibrunat 140mg Capsule consists of the active ingredient Ibrutinib. It is indicated to treat blood cancers such as mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (CLL), Waldenstrom’s macroglobulinemia, and Marginal zone lymphoma (MZL). These are cancers of the white blood cells called lymphocytes that are part of the immune system. They differ from each other by the location where cancer occurs, type of lymphocytes affected, and certain other factors
Ibrunat 140mg Capsule is also used to treat chronic graft versus host disease (cGvHD ) after the failure of systemic therapy. During allogeneic stem cell transplantation, the patient receives stem cells from the donor. GvHD occurs when donor cells view the patient’s cells as foreign and attack them. Before taking Ibrutinib Capsule, you need to talk with your physician if you have bleeding problems, infection, liver problems, heart problems, or intolerance to some sugars. This medication is not recommended for adolescents and children.

Uses
Mantle cell lymphomaChronic lymphocytic leukemia (Blood cancer)Small lymphocytic lymphomaWaldenstrom’s macroglobulinemiaChronic graft vs. host disease after failure of systemic therapy

Storage
Store the capsules in the original packaging at room temperature (20-25°C).

Side Effects
Bleeding problemsInfectionsDecrease in blood cell countsHeart problemsHigh BPSecondary cancerTumor lysis syndromeSevere allergic reactionsNausea, vomiting, diarrheaTirednessMuscle and bone painRash and bruisingMouth soresPneumoniaFever, chillsBreathlessnessConstipationDizzinessBody painSwollen ankles and feetIncreased creatinine levels in bloodHeavier periods and blood in urineBlurred visionWeakness and numbness

Strength (Dose per ml)	40 mg/ml
Strength	40 mg
Invoice Type	With GST Bill
Packaging Type	1 Vial
Manufacturer	Bayer
Usage / Application	Wet AMD
Usage/Application	Hospital
Composition	Aflibercept 40mg
Injectable Form	Liquid
Packaging Size	1 Vial
Also Gives	PCD Pharma Franchise
Brand	Bayer Zydus Pharma Pvt Ltd
Shelf Life	24 Months
Country of Origin	Made in India

Eylea 40mg/ml Injection contains the active constituent Aflibercept. Eylea. It is used to treat eye conditions in which impaired vision occurs due to the formation of an abnormal blood vessel inside the eye. These include wet age-related macular degeneration and diabetic macular edema. In studies, this medication effectively reduces the risk of vision loss and improves visual acuity in people with these conditions. Most patients generally well-tolerated it, and the injection procedure is relatively quick and minimally invasive.

Uses

• Neovascular (wet) age-related macular degeneration (wet AMD)
• Diabetic macular edema (DME)
• Myopic choroidal neovascularization (myopic CNV)
• Macular edema secondary to retinal vein occlusion

More Information

• Store in a refrigerator at 2-8°C.
• Do not freeze.
• Protected from light.
• Keep it in its original packaging until it is ready to be used.
• Keep out of the reach of children and pets.
• Should be disposed of properly.

Safety Advices Pregnancy  

There is limited information available that Eylea 40mg/ml Injection is used in pregnancy or not. So women should consult their doctor if they are pregnant or planning to become pregnant before taking this medication.  

Breast Feeding  

It is unclear whether Eylea 40mg/ml Injection is excreted in human milk. So you should consult a doctor before taking this medication if you are a breastfeeding mother.  

Lungs  

Patients, after taking Aflibecept, may experience pulmonary adverse events, such as shortness of breath, coughing, and interstitial lung disease. Therefore, patients with pre-existing lung conditions, such as COPD (chronic obstructive pulmonary disease) or asthma, may be at an increased risk of developing pulmonary adverse events when receiving this medication.  

Liver  

Eylea 40mg/ml Injection is primarily metabolized in the liver, so inform your healthcare provider if you have any liver problems or diseases. This medication may also increase liver enzymes, which can be liver damage sign or inflammation. Patients taking this medication require regular blood tests to monitor liver function.  

Alcohol  

There is no known interaction between Eylea 40mg/ml Injection and alcohol. But in high amounts, alcohol can worsen the liver-related side effect. So patients should consult the doctor before taking alcohol while taking this medication.  

Driving  

Eylea 40mg/ml Injection may cause side effects such as blurred vision, affecting a patient's ability to drive or operate heavy machinery. Patients should wait until their vision is normal before driving or operating machinery.

Side Effects

• Blood clots or stroke
• Heart attack
• Severe bleeding or hemorrhage
• Gastrointestinal perforation (a hole in the stomach or intestine)
• Severe infections
• Hypertensive crisis (a sudden and severe increase in blood pressure)

• Eye pain, irritation, or redness
• Blurred vision
• Increased tear production
• Sensitivity to light
• Headache
• High blood pressure
• Nasal congestion
• Nausea
• Vomiting
• Diarrhea
• Back pain
• Joint pain

Strength	450 mg
Packaging Size	1*10 Tablets
Brand	Virolfi
Pack Size	10 tablets
Dose Form	Tablet
Manufacturer	Zydus Cadila
Indication	CMV retinitis
Composition	Valganciclovir 450mg
Treatment	Treatment of Cytomegalovirus Infection
Prescription/Non prescription	Prescription
Usage / Application	Personal
Packaging Type	Stripe
Shelf Life	24 Months
Also gives	PCD Pharma

Virolfi 450mg tablet is an Antiviral with an active ingredient called Valganciclovir. It belongs to the medication group known as Antiviral (Non-HIV) drugs. Valganciclovir is converted into Ganciclovir after entering the body, which acts to fight viral infections. It is used to treat Cytomegalovirus (CMV) infections of the retina of the eye in adults with Acquired immune deficiency syndrome (AIDS). Cytomegalovirus infection often leads to vision problems and blindness. Additionally, it prevents Cytomegalovirus (CMV) infections in patients who received an organ transplant from a person infected with CMV in adults and children.   

Uses

• Treatment and prevention of Cytomegalovirus (CMV) infection

More Information

• Keep out of sight and reach of pets and children
• Store at room temperature between 15°C to 30°C.
• Do not freeze.

Safety Advices Pregnancy  

Taking Virolfi 450mg tablet while pregnant can harm the baby. You should not take this medicine during the pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to get pregnant before taking this medicine. Use effective contraception to avoid pregnancy.  

Breast Feeding  

Taking Virolfi 450mg tablet while breastfeeding may be unsafe because it may affect the child. Talk to your physician to get more information.   

Lungs  

It is unknown whether Virolfi 450mg tablet  is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

It is unknown whether Virolfi 450mg tablet is safe to administer in patients with liver problems. Inform your physician if you have any liver disease before starting the treatment. Contact your doctor if you experience any liver-related symptoms.  

Alcohol  

It is unknown whether consuming alcohol while taking a Virolfi 450mg tablet is safe. Please speak with your physician.  

Driving  

While taking Virolfi 450mg tablet , it is unsafe to drive or use machines because it may cause dizziness, shaky, changes in vision, etc. Talk to your doctor for more information. 

Side Effects

• Anaphylactic shock (sudden swelling of the throat, face, lips, hand, ankles, difficulty swallowing, itchy skin rash)
• Low blood counts (shortness of breath, pale skin, mouth ulcers, sore throat)
• Blood infection
• Severe stomach pain which spreads into your back
• Seizures

• Respiratory tract infections
• Loss of appetite
• Headache, Dizziness
• Cough, fever
• Diarrhea, constipation
• Tiredness, feeling sick
• Infections in the urinary tract, skin
• Weight loss
• Anxious, confused, depression
• Troubled sleeping
• Abnormal sensation of skin (tickling, pricking, burning, tingling)
• Changes in taste
• Eye, ear pain
• Night sweats
• Joint pain, muscle spasms
• Hair loss
• Low blood pressure

Strength	50 mg
Brand	Invista
Tablets per Pack	10 tablets
Pack Size	1*10 Tablet
Pack Type	Strips
Pack Type	Blister
Form	Tablet
Storage Condition	Store protected from light at a temperature not exceeding 30c.
Brand Name	Invista
Prescription/Non prescription	Prescription
Manufacturer	DR REDDY'S LABORATORIES LTD
Usages	Children and adults with chronic myeloid leukemia.
Country of Origin	Made in India

Invista 50mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long. 

The common side effects that are likely to associate with Invista 50mg tablet are diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, and high or low blood pressure. Inform your doctor if these side effects disturb or persist you. 

Inform your doctor if you are allergic to Dasatinib and its ingredients. Before starting treatment with this medication, you should let your physician know if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, or bleeding problems. This medicine could cause a severe reduction in the number of platelets, WBC, or RBC in the blood. Ensure that your physician monitors your blood levels at regular intervals. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. It is not recommended for children below one year of age.

Uses of Invista 50mg Tablet

Invista 50mg tablet is indicated for the following conditions

• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

 

More Information

• Store protected from light at a temperature not exceeding 30c. 

Safety Advices Pregnancy  

Invista 50mg tablet is not recommended during pregnancy unless necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.   

Breast Feeding  

It is not recommended to breastfeed while taking Invista 50mg tablet as it is unknown whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.  

Lungs  

It is unknown whether Invista is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.  

Liver  

Inform your physician before starting this treatment if you have liver diseases. Your physician will prescribe a dose accordingly.  

Alcohol  

It is not known whether it is safe to consume alcohol with Invista 50mg tablet. Consult your doctor for advice.  

Driving  

Avoid driving or using machinery if you experience symptoms like breathlessness or altered consciousness.

Side Effects

• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction

• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP

Strength	70 mg
Brand	Invista
Tablets per Pack	10 Tablets
Pack Size	1*10 Tablet
Pack Type	Strips
Pack Type	Blister
Form	Tablet
Storage Condition	Store protected from light at a temperature not exceeding 30c.
Prescription/Non prescription	Prescription
Brand Name	Invista
Manufacturer	DR REDDY'S LABORATORIES LTD
Usages	Children and adults with chronic myeloid leukemia.
Country of Origin	Made in India

Invista 70mg tablet consists of the active ingredient Dasatinib. It is prescribed for adults and children above one year of age with Chronic Myeloid Leukemia. This medicine is used to treat newly diagnosed Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in the chronic phase and Ph+ acute lymphoblastic leukemia in patients resistant to other therapies. Chronic Myeloid Leukemia refers to a type of blood cancer that makes the body produce too many white blood cells that happen due to alteration in the Philadelphia chromosome. Acute Lymphoblastic Leukemia is the most common form of blood cancer that affects children. In this case, the lymphocytes of white blood cells multiply too quickly and live too long. 

The common side effects that are likely to associate with Invista 70mg tablet are diarrhea, headache, cough, rash, nausea, tiredness, vomiting, muscle pain, weakness, low appetite, and high or low blood pressure. Inform your doctor if these side effects disturb or persist you. 

Inform your doctor if you are allergic to Dasatinib and its ingredients. Before starting treatment with this medication, you should let your physician know if you have liver or heart problems, breathing difficulties, chest pain, cough, hepatitis B infection, or bleeding problems. This medicine could cause a severe reduction in the number of platelets, WBC, or RBC in the blood. Ensure that your physician monitors your blood levels at regular intervals. Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, antacids, and herbal supplements. It is not recommended for children below one year of age.

Uses of Invista 70mg Tablet

Invista 70mg tablet is indicated for the following conditions

• Children and adults with chronic myeloid leukemia.
• Adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) with resistance to prior therapy.

More Information

• Store protected from light at a temperature not exceeding 30c.

Safety Advices Pregnancy  

Invista 70mg tablet is not recommended during pregnancy unless necessary. Your physician will discuss the potential risk during pregnancy. Women should use effective birth control during treatment and 30 days after the final dose.   

Breast Feeding 

It is not recommended to breastfeed while taking Invista 70mg tablet as it is unknown whether this medication passes into breast milk. You should not breastfeed during treatment and for 2 weeks after your final dose.  

Lungs  

It is unknown whether Invista is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment.  

Liver  

Inform your physician before starting this treatment if you have liver diseases. Your physician will prescribe a dose accordingly.  

Alcohol  

It is not known whether it is safe to consume alcohol with Invista 70mg tablet. Consult your doctor for advice.  

Driving  

Avoid driving or using machinery if you experience symptoms like breathlessness or altered consciousness.

Side Effects

• Unusual bleeding or bruising
• Rapid heart rate
• Changes in consciousness or speech
• Breathlessness and swelling all over the body
• Fever or signs of infection
• Fluid retention
• Heart problems
• Myelosuppression
• Severe allergic reaction

• Diarrhea
• Headache
• Cough
• Rash
• Nausea, tiredness, vomiting
• Muscle pain, weakness
• Low appetite
• High or low BP

Treatment Type	Leukemia
Strength	10000 iu
Formulation Type	PEG-Conjugated
Brand	Lagicad
Packaging Type	Vial
Manufacturer	Oncocare
Form	Injection
Storage Temperature	2-8 degree c
Shelf Life	18 months
Dosage Form	Injection
Storage Condition	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Lagicad 10000IU Injection contains L-asparaginase. It is used to treat Acute Lymphoblastic Leukemia (cancer of white blood cells) in patients aged four months and above. In Acute Lymphoblastic Leukemia, the white blood cells called lymphocytes multiply in an uncontrolled and abnormal manner. This disorder is also known as Acute Lymphocytic Leukemia. 

This medicine should not be used if you have severe problems with your pancreas or allergic to any of the ingredients of this medicine. Talk to your physician if you are a diabetic patient as this medicine contains glucose. The common side effects of Lagicad 10000IU Injection are muscle pain, nausea, infections, abdominal pain, and diarrhea.  

Use effective birth control during the treatment with Lagicad 10000IU Injection and for at least three months after the last dose. Women should use contraception methods other than oral contraceptives.

Uses of Lagicad 10000iu Injection

• Acute Lymphoblastic Leukemia (ALL)

Therapeutic Effects of Lagicad 10000iu Injection

Cancer cells need a substance called asparagine to survive. Lagicad  10000IU Injection works by lowering the levels of asparagine in the body.

Interaction of Lagicad 10000iu Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products that  you are taking or have taken before the treatment. Certain medications may interact with Lagicad 10000IU injection and can cause undesirable side effects.

More Information about Lagicad 10000iu Injection

• Keep Lagicad 10000IU Injection out of sight and reach of children.
• Store in a refrigerator (2°C to 8°C).

How to consume Lagicad 10000iu Injection

It will be given to you by your health care professional. Do not self-administer. Your physician will decide the dose and duration of your treatment based on the disease severity and other factors.

Safety Advices Pregnancy  

You need to tell your physician if you are pregnant or planning to get pregnant before taking Lagicad 10000IU  Injection. it will be given to you if clearly needed.  

Breast Feeding  

You must not breastfeed your baby during treatment with Lagicad 10000IU Injection. You need to tell your physician if you are breastfeeding before taking this medicine.   

Lungs  

You need to tell your physician if you have any lung disorders before taking Lagicad 10000IU Injection.  

Liver  

You must tell your physician if you have any liver disorders before taking Lagicad 10000IU Injection.  

Alcohol  

It is not known whether it is safe to consume alcohol with Lagicad 10000IU Injection. Please consult your doctor.  

Driving  

Lagicad 10000IU Injection can cause dizziness and drowsiness. Avoid driving if you are unwell.

Side Effects

• Severe allergic reactions
• High blood sugar levels
• Bleeding
• Liver and nervous problems
• Pain near your stomach (inflammation of the pancreas)
• Blood clots in arm or leg
• Pain, bruising, swelling, or hardening of the skin at the injection site

• Nausea
• Muscle pain
• Weight loss
• Infections (fever, rapid heart rate, confusion, or a rash)
• Difficulty breathing
• Inflammation of the digestive tract
• Diarrhea
• Abdominal pain, discomfort
• Headache
• Tiredness

Dose/Strength	400 mg
Strength	400 mg
Brand	Levin
Composition	Imatinib Mesylate
Packaging Size	10 Tablets
Manufacturer	Dr Reddys
Usage	CML
Tablets per Pack	10 Tablets
Packaging Type	Box
Storage Condition	Store Levin 400mg tablet in room temperature (25 DegreeC).
Prescription/Non prescription	Prescription
Shelf Life	24 months
Usage/Application	Personal
Form	Tablet
Country of Origin	Made in India

Levin 400mg tablet contains the active substance imatinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. This tablet is used in treating adults and children with chronic myeloid leukemia (CML- it is a form of leukemia in which certain abnormal white blood cells start growing out of control). It is also indicated to treat Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL). It is also used to treat certain types of gastrointestinal stromal tumors (GIST, a type of tumor that grows in the walls of the digestive passages and may spread to other parts of the body). 

Uses

• Chronic myeloid leukemia (CML)
• Philadelphia chromosome positive acute lymphoblastic leukemia (ph-positive ALL)
• Myelodysplastic/myeloproliferative diseases (MDS/MPD)
• Hypereosinophilic syndrome (HES)
• Chronic eosinophilic leukemia (CEL)
• Dermatofibrosarcoma protuberans (DFSP)
• Gastrointestinal stromal tumors (GIST)

More Information

• Store Levin 400mg tablet in room temperature (25°C)
• Keep the injection away from the reach of children and pets.
• If you forgot to take a dose, take it as soon as you remember. However, if it is nearly time for the next dose, skip the missed dose.
• Do not take a double dose to make up for a forgotten dose.
• Avoid direct contact with crushed tablets with the skin or mucous membrane. If such contact occurs, wash thoroughly.

Safety Advices  Pregnancy  

Levin 400mg tablet is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant. Using an effective birth control method during the treatment and for 15 days after your last dose is necessary.    

Breast Feeding  

Breastfeeding is not recommended in patients taking Levin 400mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby.  

Lungs  

It is unknown whether Levin 400mg tablet can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Levin 400mg tablet is unsafe when administered in patients with severe liver diseases. Dose adjustments are necessary in severe liver failure. Inform your physician if you have liver problems before initiating the therapy.    

Alcohol  

It is unknown whether it is safe to consume alcohol when taking Levin 400mg tablet. Consult your doctor for more advice.  

Driving  

It is unsafe to drive or operate heavy machinery after taking Levin 400mg tablet because you may feel dizzy, drowsy, or get blurred vision.

Side Effects

• Swelling in the face, legs, ankle, and feet
• Nausea, vomiting
• Muscle cramps and pain
• Diarrhea
• Skin rash, night sweats
• Tiredness, dizziness
• Abdominal pain
• Increased weight
• Decreased RBC and WBC cells
• Headache
• Cough, Inflammation in the nose
• Fever, lack of sleep

• Heart failure
• GI disorders
• Hypothyroidism
• Liver failure
• Swelling in the body

Strength	25 mg
Composition	Lorlatinib
Pack Size	30 Tablets
Brand	Lorbrena
Form	Tablet
Usage	NSCLC
Storage Condition	Store Lorbriqua 25mg tablet in the original package at a controlled room temperature (20 DegreeC to 25 DegreeC).
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Lorbriqua 25mg tablet is a drug belonging to the class of tyrosine kinase inhibitors, containing the active ingredient Lorlatinib. It is used to treat metastatic non-small cell lung cancer (NSCLC). This is the most common type of lung cancer. Metastatic non-small cell lung cancer (NSCLC) is a type of lung cancer that has spread to other parts of the body, such as the bones, liver, brain, or other organs.

During the treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes, and kidney parameters to prevent serious complications. This medicine has the potential to cause liver damage. Also, it may cause decreased fertility in males and this could affect your ability to father a child. Talk to your healthcare provider if you have concerns about fertility.

Inform the doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment. Report to your doctor if you experience any hypersensitive reactions like itchy skin or rashes while taking this medicine. It is advised to avoid drinking grapefruit juice while taking this drug, as it may increase the level of the drug in the blood and cause side effects. This tablet contains lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating, and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy.

Uses of Lorbriqua 25mg Tablet

• Metastatic non-small cell lung cancer (NSCLC)

 

More Information

• Store Lorbriqua 25mg tablet in the original package at a controlled room temperature (20°C to 25°C).
• Keep it out of reach from children.

Safety Advices Pregnancy  

Lorbriqua 25mg tablet is not recommended for pregnant women as it may cause fetal harm. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding  

It is not known if Lorbriqua 25mg tablets pass into your breast milk or if it will affect your baby. Please consult your doctor before breastfeeding.   

Lungs  

Inform your doctor if you have any lung problems before taking Lorbriqua 25mg tablet. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

Inform your doctor if you have any liver problems before taking Lorbriqua 25mg tablet. Regular monitoring of liver function tests is recommended.  

Alcohol  

Consuming alcohol may affect the effectiveness of Lorbriqua 25mg tablet. Stop consuming alcohol if you are taking this medicine.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking Lorbriqua 25mg tablets, it may cause dizziness and impair your concentration.

Side Effects

• Cough, chest pain, or worsening of breathing problems
• Feeling tired, faint, or losing consciousness
• Yellowing of the skin and eyes, vomiting, abdominal pain
• Confusion, memory loss, mood swings, difficulty speaking, seeing, or hearing things that are not real

• Increase in cholesterol levels
• Swelling in hand or legs
• Double vision difficulty seeing
• Pain, numbness, or unusual sensations (burning or pin and needles) in arms and legs, difficulty walking
• Diarrhoea, constipation
• Headache
• Weight gain
• Joint pain, muscle pain
• Rash
• Anaemia

Strength	300 mg
Pack Size	60 tablets
Brand	Ruparib
Composition	Rucaparib 300 mg
Indication	Ovarian Cancer
Prescription Type	Rx Only
Storage Condition	Store at 20 DegreeC to 25 DegreeC
Prescription/Non prescription	Prescription
Form	Tablet
Country of Origin	Made in India

Ruparib 300mg tablet contains the active ingredient rucaparib. It is an anti-cancer medicine that belongs to the class of medications called PARP (poly ADP-ribose polymerase) inhibitors. It is used to help maintain the response to other treatments for certain types of ovarian cancer, fallopian tube (a tube that transports eggs released by the ovaries to the uterus), and primary peritoneal (layer of tissue that lines the abdomen) cancer that has reoccurred in adults who have previously completely responded or partially responded to other chemotherapy treatments. 

It is also used to treat certain types of cancer in people with specific gene (BRCA) changes who have received treatment with at least two other chemotherapy treatments. It is also indicated as maintenance therapy immediately after chemotherapy which has caused the tumor to shrink. Do not take Ruparib 300mg tablet if you are allergic to Ruparib or any of the ingredients. This medication can cause low blood counts; hence your healthcare professional will advise you to take certain blood tests before and every month during the treatment.  

Inform your doctor if you have nausea, vomiting, diarrhea, or abdominal pain during the treatment because this medicine may affect your stomach or bowels. Ruparib 300mg tablet should not be given to children under 18 years of age. Notify your physician if you are pregnant, breastfeeding, suspecting, or planning for pregnancy during the treatment with this medicine. Women with reproductive potential should use effective contraception during the treatment.

Uses of Ruparib 300mg Tablet

• Ovarian cancer
• Fallopian tube cancer
• Primary peritoneal cancer
• Prostate cancer

 

More Information

• Store at 20°C to 25°C
• Protect the medicine from light and excessive moisture.
• Keep the medicine out of reach of children and pets
• If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.

Safety Advices Pregnancy  

Do not take Ruparib 300mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 6 months after the last dose. Ruparib   

Breast Feeding  

Breastfeeding is not recommended in patients taking Ruparib 300mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.   

Lungs  

It is unknown whether Ruparib 300mg tablet is safe to be administer in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.  

Liver  

Ruparib 300mg tablet is safe when administered in patients with liver disease. No dose adjustments are necessary.   

Alcohol  

It is not known whether it is safe to consume alcohol with Ruparib 300mg tablet. Please consult your doctor.  

Driving  

Ruparib 300mg tablet may cause dizziness and drowsiness. Driving or operating heavy machinery is unsafe if you experience any symptoms that affect your ability to concentrate and react.

Side Effects

• Rash
• Constipation
• Decrease in appetite
• Diarrhea, indigestion
• Nausea, vomiting
• Changes in the blood count
• Shortness of breath
• Tiredness

• Severe anemia
• Hypersensitivity reactions
• Sepsis (blood infection)
• Pneumonia

Strength	250 mg
Brand	Crizalk
Dose/Strength	250 mg
Packaging Size	60 Capsules
Form	Capsule
Dose Type	Oral
Indication	ALK+ NSCLC
Manufactured By	Pfizer
Compostion	Crizotinib
Prescription/Non prescription	Prescription
Country of Origin	Made in India
Treatment	Treating Non-small Cell Lung Cancer.
Item Form	Capsule

Know About Pap Introduction to Crizalk 250mg Capsule

Crizalk 250mg contains the active substance Crizotinib. It is an antineoplastic drug that belongs to the class of tyrosine kinase inhibitors. This medicine is prescribed to treat patients with a type of lung cancer called Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) that is locally advanced or metastatic (spread outside the lungs or to other parts of the body). Do not take this capsule if you are allergic to Crizotinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have had kidney, stomach, heart, or liver problems. 

Notify your doctor if you have reduced white blood cells, abnormal heart tracing after ECG, vision problems, or if you take other medications. Report your doctor immediately if you are planning to get pregnant or think you may be pregnant. Talk to your doctor about effective contraceptives. Use effective birth control during the treatment because oral contraception is ineffective with this medicine and use it at least for 90 days even after completing the therapy with Crizalk 250mg capsule. It is advised to get suggestions about fertility concerns from your doctor. This medication is not recommended for adolescents and children under 18 years of age. Use a sunscreen or protective clothing to cover the skin to protect them against sunburn.

Uses of Crizalk 250mg Capsule:

• Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC)

Therapeutic Effects of Crizalk 250mg Capsule:

Crizalk 250mg is a tyrosine kinase inhibitor that works by blocking the activity of the anaplastic lymphoma kinase (ALK) protein. It specifically targets the abnormal protein and blocks its activity, slowing down or stopping the growth and spread of cancer cells.

Interaction of Crizalk 250mg Capsule with other drugs:

Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, recent vaccinations, nutritional and vitamin supplements, and herbal products. Certain medications such as Erythromycin, Diltiazem, Verapamil, and other medications may interact with Crizalk 250mg and reduce its effectiveness by causing undesirable side effects. 

More Information about Crizalk 250mg Capsule:

• Store at room temperature (15-30˚C) in the original container 
• Keep this medicine out of the sight and reach of children.

Strength	200 mg
Brand	Crizalk
Packaging Size	60 Capsules
Form	Capsule
Dose Type	Oral
Indication	ALK+ NSCLC
Pack Type	Blister
Shelf Life	24 Months

Crizalk 200mg contains the active substance Crizotinib. It is an antineoplastic drug that belongs to the class of tyrosine kinase inhibitors. This medicine is prescribed to treat patients with a type of lung cancer called Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) that is locally advanced or metastatic (spread outside the lungs or to other parts of the body). Do not take this capsule if you are allergic to Crizotinib or any other ingredients of this medicine. Before initiating the treatment, inform your physician if you have had kidney, stomach, heart, or liver problems. 
Notify your doctor if you have reduced white blood cells, abnormal heart tracing after ECG, vision problems, or if you take other medications. Report your doctor immediately if you are planning to get pregnant or think you may be pregnant. Talk to your doctor about effective contraceptives. Use effective birth control during the treatment because oral contraception is ineffective with this medicine, and use it at least for 90 days even after completing the therapy with Crizalk 200mg capsule. It is advised to get suggestions about fertility concerns from your doctor. This medication is not recommended for adolescents and children under 18 years of age. Use sunscreen or protective clothing to cover the skin and protect it against sunburn. Crizalk 200mg price is based on the seller and location. Crizalk substitutes include Xalkori, Alectinib, Ceritinib, Lorlatinib, and Brigatinib, which are also used for ALK-positive non-small cell lung cancer.
UsesAnaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC).
Storage
Store at room temperature (15-30˚C) in the original container.Keep this medicine out of the sight and reach of children.
Side Effects
Pain on the right of the stomachPartial or full loss of visionLowered WBCLow heart rate.Swelling of the lungs.BreathlessnessCough with or without mucus
Sensitivity to sunlightDiarrhoeaFeverConstipationNauseaIncreased liver enzymesDecreased appetite, Tiredness (fatigue)DizzinessNeuropathy (weakness, tingling, or numbness in the nerve)Dysgeusia (taste disorder)Hypophosphataemia (low levels of phosphate in the blood)

Strength	450 mg
Packaging Size	1*10 Tablets
Brand	Valcip
Pack Size	10 tablets
Dose Form	Tablet
Manufacturer	Cipla Ltd
Indication	CMV retinitis
Composition	Valganciclovir 450mg
Treatment	Treatment of Cytomegalovirus Infection
Prescription/Non prescription	Prescription
Usage / Application	Personal
Packaging Type	Stripe
Shelf Life	24 Months
Also gives	PCD Pharma

Valcip 450mg tablet is an Antiviral with an active ingredient called Valganciclovir. It belongs to the medication group known as Antiviral (Non-HIV) drugs. Valganciclovir is converted into Ganciclovir after entering the body, which acts to fight viral infections. It is used to treat Cytomegalovirus (CMV) infections of the retina of the eye in adults with Acquired immune deficiency syndrome (AIDS). Cytomegalovirus infection often leads to vision problems and blindness. Additionally, it prevents Cytomegalovirus (CMV) infections in patients who received an organ transplant from a person infected with CMV in adults and children.  

Uses

• Treatment and prevention of Cytomegalovirus (CMV) infection

More Information

• Keep out of sight and reach of pets and children
• Store at room temperature between 15°C to 30°C.
• Do not freeze.

Safety Advices Pregnancy  

Taking Valcip 450mg tablet while pregnant can harm the baby. You should not take this medicine during the pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to get pregnant before taking this medicine. Use effective contraception to avoid pregnancy.  

Breast Feeding  

Taking Valcip 450mg tablet while breastfeeding may be unsafe because it may affect the child. Talk to your physician to get more information.   

Lungs  

It is unknown whether Valcip 450mg tablet  is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

It is unknown whether Valcip 450mg tablet is safe to administer in patients with liver problems. Inform your physician if you have any liver disease before starting the treatment. Contact your doctor if you experience any liver-related symptoms.  

Alcohol  

It is unknown whether consuming alcohol while taking a Valcip 450mg tablet is safe. Please speak with your physician.  

Driving  

While taking Valcip 450mg tablet , it is unsafe to drive or use machines because it may cause dizziness, shaky, changes in vision, etc. Talk to your doctor for more information. 

Side Effects

• Anaphylactic shock (sudden swelling of the throat, face, lips, hand, ankles, difficulty swallowing, itchy skin rash)
• Low blood counts (shortness of breath, pale skin, mouth ulcers, sore throat)
• Blood infection
• Severe stomach pain which spreads into your back
• Seizures

• Respiratory tract infections
• Loss of appetite
• Headache, Dizziness
• Cough, fever
• Diarrhea, constipation
• Tiredness, feeling sick
• Infections in the urinary tract, skin
• Weight loss
• Anxious, confused, depression
• Troubled sleeping
• Abnormal sensation of skin (tickling, pricking, burning, tingling)
• Changes in taste
• Eye, ear pain
• Night sweats
• Joint pain, muscle spasms
• Hair loss
• Low blood pressure

Strength	450 mg
Packaging Size	1*10 Tablets
Brand	Cymgal
Pack Size	10 tablets
Dose Form	Tablet
Manufacturer	Eris Lifesciences Ltd
Indication	CMV retinitis
Composition	Valganciclovir 450mg
Treatment	Treatment of Cytomegalovirus Infection
Prescription/Non prescription	Prescription
Usage / Application	Personal
Packaging Type	Stripe
Shelf Life	24 Months
Also gives	PCD Pharma

Cymgal 450mg tablet is an Antiviral with an active ingredient called Valganciclovir. It belongs to the medication group known as Antiviral (Non-HIV) drugs. Valganciclovir is converted into Ganciclovir after entering the body, which acts to fight viral infections. It is used to treat Cytomegalovirus (CMV) infections of the retina of the eye in adults with Acquired immune deficiency syndrome (AIDS). Cytomegalovirus infection often leads to vision problems and blindness. Additionally, it prevents Cytomegalovirus (CMV) infections in patients who received an organ transplant from a person infected with CMV in adults and children.  

Uses

• Treatment and prevention of Cytomegalovirus (CMV) infection

More Information

• Keep out of sight and reach of pets and children
• Store at room temperature between 15°C to 30°C.
• Do not freeze.

Safety Advices Pregnancy  

Taking Cymgal 450mg tablet while pregnant can harm the baby. You should not take this medicine during the pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to get pregnant before taking this medicine. Use effective contraception to avoid pregnancy.  

Breast Feeding  

Taking Cymgal 450mg tablet while breastfeeding may be unsafe because it may affect the child. Talk to your physician to get more information.   

Lungs  

It is unknown whether Cymgal 450mg tablet  is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

It is unknown whether Cymgal 450mg tablet is safe to administer in patients with liver problems. Inform your physician if you have any liver disease before starting the treatment. Contact your doctor if you experience any liver-related symptoms.  

Alcohol  

It is unknown whether consuming alcohol while taking a Cymgal 450mg tablet is safe. Please speak with your physician.  

Driving  

While taking Cymgal 450mg tablet , it is unsafe to drive or use machines because it may cause dizziness, shaky, changes in vision, etc. Talk to your doctor for more information. 

Side Effects

• Anaphylactic shock (sudden swelling of the throat, face, lips, hand, ankles, difficulty swallowing, itchy skin rash)
• Low blood counts (shortness of breath, pale skin, mouth ulcers, sore throat)
• Blood infection
• Severe stomach pain which spreads into your back
• Seizures

• Respiratory tract infections
• Loss of appetite
• Headache, Dizziness
• Cough, fever
• Diarrhea, constipation
• Tiredness, feeling sick
• Infections in the urinary tract, skin
• Weight loss
• Anxious, confused, depression
• Troubled sleeping
• Abnormal sensation of skin (tickling, pricking, burning, tingling)
• Changes in taste
• Eye, ear pain
• Night sweats
• Joint pain, muscle spasms
• Hair loss
• Low blood pressure

Strength	250 mg
Dose/Strength	250 mg
Brand	Geftib
Packaging Size	30 tablets
Composition	Gefitinib
Dosage Form	Tablet
Form	Tablet
Prescription	Prescription
Storage Condition	Store Geftib 250mg Tablet in the original package at room temperature (25 DegreeC).
Usage/Application	Personal
Prescription/Non prescription	Prescription
Manufacturer	GLENMARK PHARMACEUTICALS LTD
Shelf Life	24 Months
Packaging Type	Box

Geftib 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.

Some formulations of this drug may contain lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating, and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.

Consult your doctor before using this medication if you are pregnant or plan to have a baby. These tablets are unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this tablet. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Avoid breastfeeding your baby while on the treatment as it is unknown if this drug passes into the breast milk.

Uses of Geftib 250mg Tablet

Geftib 250mg Tablet is used to treat

• Non-small cell lung cancer.

More Information

• Store Geftib 250mg Tablet in the original package at room temperature (25°C).
• Keep it out of reach from children.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.

Safety Advices   Pregnancy  

It is unsafe to use during pregnancy whether Geftib 250mg Tablet can be taken during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding

It is unsafe to breastfeed during the treatment with this Geftib 250mg Tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.  

Lungs

It is unknown whether Geftib 250mg Tablet can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver

It is unknown whether Geftib 250mg Tablet can be used for patients with liver disorders. Inform your physician if you have any liver problems before starting treatment.  

Alcohol

It is unknown whether consuming alcohol interacts with the Geftib 250mg Tablet. Please consult your doctor for more advice.  

Driving

It is unsafe to drive vehicles or operate heavy machinery after taking the Geftib 250mg Tablet because it contains a small amount of alcohol which may cause dizziness and impair your concentration.

Side Effects

• diarrhea
• nausea
• vomiting
• loss of appetite
• weakness
• red or sore mouth
• increased liver enzymes
• itchy or cracked skin
• dry mouth
• red or itchy eyes
• nail problems
• hair loss
• fever
• blood in the urine and burning sensation while urinating

Strength	250 mg
Dose/Strength	250 mg
Brand	Gefzest
Packaging Size	30 tablets
Composition	Gefitinib
Dosage Form	Tablet
Form	Tablet
Prescription	Prescription
Storage Condition	Store Gefzest Tablet in the original package at room temperature (25 DegreeC)
Usage/Application	Personal
Prescription/Non prescription	Prescription
Manufacturer	ZEE LABORATORIES LTD
Shelf Life	24 months
Packaging Type	Box

Gefzest 250mg Tablet is an antineoplastic drug belonging to the tyrosine kinase inhibitors, containing the active ingredient Gefitinib. It is used to treat non-small cell lung cancer. Non-small cell lung cancer is a disorder in which cells multiply in an uncontrolled and abnormal manner in the tissues of the lung. It is used in patients where the NSCLC cancer has spread to other parts of the body, who have certain types of abnormal epidermal growth factor (EGFR) genes, and patients who have not received any cancer treatment.

Some formulations of this drug may contain lactose as an inactive ingredient in which the body is unable to digest lactose, a sugar found in milk and dairy products. It can cause symptoms such as bloating, and abdominal pain. If you have lactose intolerance, inform your doctor before starting this therapy. Talk with your healthcare provider if you have kidney or liver disease, vision problems, lung problems, or taking any blood thinner like warfarin. Your healthcare provider will check regular blood tests to prevent complications. Avoid consuming alcohol as it may cause dizziness.

Consult your doctor before using this medication if you are pregnant or plan to have a baby. These tablets are unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this tablet. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Avoid breastfeeding your baby while on the treatment as it is unknown if this drug passes into the breast milk.

Uses of Gefzest 250mg Tablet

Gefzest 250mg Tablet is used to treat

• Non-small cell lung cancer.

More Information

• Store Gefzest 250mg Tablet in the original package at room temperature (25°C).
• Keep it out of reach from children.
• If you have missed any dosing appointments, inform your doctor and schedule immediately.

Safety Advices Pregnancy  

It is unsafe to use during pregnancy whether Gefzest 250mg Tablet can be taken during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.  

Breast Feeding  

It is unsafe to breastfeed during the treatment with this Gefzest 250mg Tablet because it may cause harm to the baby. Please consult your doctor before breastfeeding.  

Lungs  

It is unknown whether Gefzest 250mg Tablet can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

It is unknown whether Gefzest 250mg Tablet can be used for patients with liver disorders. Inform your physician if you have any liver problems before starting treatment.  

Alcohol  

It is unknown whether consuming alcohol interacts with the Gefzest 250mg Tablet. Please consult your doctor for more advice.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking the Gefzest 250mg Tablet because it contains a small amount of alcohol which may cause dizziness and impair your concentration.

Side Effects

• diarrhea
• nausea
• vomiting
• loss of appetite
• weakness
• red or sore mouth
• increased liver enzymes
• itchy or cracked skin
• dry mouth
• red or itchy eyes
• nail problems
• hair loss
• fever
• blood in the urine and burning sensation while urinating

Strength	100 mg/5 ml
Vial Volume	5 ml
Strength per ml	5 mg/ml
Brand	Intensic
Composition	Irinotecan HCl Trihydrate
Packaging Type	Vial
Storage Condition	Store protected from light at a temperature not exceeding 25 DegreeC
Manufacturer	NEON LABORATORIES LTD
Prescription/Non prescription	Prescription
Form	Injection
Shelf Life	24 Months
Indication	Colorectal Cancer
Country of Origin	Made in India

Intensic 100mg Injection belongs to the group of medications called anti-cancer medicines or cytostatics. It consists of the active ingredient Irinotecan hydrochloride trihydrate. It is indicated for advanced colon cancer and rectal cancer in adults. It is prescribed alone or in combination with other chemotherapeutic agents. Cancer in the colon and rectum is prevalent in age groups above 50 and is further triggered by genetic and environmental factors.  

Myelosuppression (bone marrow suppression leading to low levels of RBC, WBC, and platelets in the blood) and diarrhea are the most common adverse effects of this medication. Other common side effects of Intensic 100mg Injection are nausea, vomiting, abdominal pain, constipation, anemia, pain, fatigue, fever, infections including sepsis, abnormal bilirubin levels, hair loss, and weight loss. Inform your doctor if these side effects disturb or persist in you.  

Inform your physician if you are allergic to Intensic 100mg Injection and its ingredients. Before starting treatment, let your physician know if you have liver problems or jaundice, kidney and heart problems, asthma, high blood pressure or high cholesterol, or severe diarrhea. If you are smoking or have ever received radiation therapy, report to your healthcare provider. Consult your healthcare provider if you take other medicines, herbs, and supplements. Effective contraception (birth control) by males and females during treatment is important to avoid pregnancy. Your physician will perform blood tests during and before treatment to check for the effects of the medicine on blood counts or blood chemistry.

Uses of Intensic 100mg Injection

Treatment of metastatic cancer of the colon and rectum (large intestine).

More Information

• Do not freeze.
• Store protected from light at a temperature not exceeding 25°C.
• Keep this medicine away from the sight and reach of children.

Safety Advices Pregnancy  

Intensic 100mg Injection is unsafe to use during pregnancy as it may harm the developing baby. Women who have potential childbearing use effective contraceptives during and after 6 months after treatment.   

Breast Feeding  

It is unsafe to use during breastfeeding as Intensic 100mg Injection and its metabolites are found in human milk. It must be discontinued for the duration of therapy. Consult your doctor for advice.  

Lungs

It is unknown whether it is safe to administer Intensic 100mg Injection in patients with lung disorders. Please consult your doctor for more advice.  

Liver

Intensic 100mg Injection is used with caution in patients with liver impairment. Inform your physician before starting treatment if you have liver disease or jaundice. Your physician will monitor your liver functions and adjust the dose accordingly.  

Alcohol

It is unknown whether it is safe to drink alcohol while taking Intensic 100mg Injection. Check with your doctor for advice.  

Driving

You may feel dizzy or tired for 24 hours after taking this medicine. Do not use any tools or drive during treatment with Intensic 100mg Injection. 

Side Effects

• Early and late diarrhea
• Allergic reactions
• Kidney impairment
• Lung problems
• Low levels of RBC, WBC, and platelets in the blood

• Nausea, vomiting, abdominal pain
• Constipation
• Diarrhea
• Anemia
• Pain
• Fatigue
• Fever, infections including sepsis
• Abnormal bilirubin levels
• Hair loss
• Weight loss

Strength	100 mg/5 ml
Vial Volume	5 ml
Strength per ml	5 mg/ml
Brand	Irnocam
Composition	Irinotecan Hydrochloride
Packaging Type	Vial
Storage Condition	Store protected from light at a temperature not exceeding 25 DegreeC.
Prescription/Non prescription	Prescription
Manufacturer	DR REDDY'S LABORATORIES LTD
Form	Injection
Shelf Life	24 months
Indication	Colorectal Cancer
Country of Origin	Made in India

Irnocam 100mg Injection belongs to the group of medications called anti-cancer medicines or cytostatics. It consists of the active ingredient Irinotecan hydrochloride trihydrate. It is indicated for advanced colon cancer and rectal cancer in adults. It is prescribed alone or in combination with other chemotherapeutic agents. Cancer in the colon and rectum is prevalent in age groups above 50 and is further triggered by genetic and environmental factors.  

Myelosuppression (bone marrow suppression leading to low levels of RBC, WBC, and platelets in the blood) and diarrhea are the most common adverse effects of this medication. Other common side effects of Irnocam 100mg Injection are nausea, vomiting, abdominal pain, constipation, anemia, pain, fatigue, fever, infections including sepsis, abnormal bilirubin levels, hair loss, and weight loss. Inform your doctor if these side effects disturb or persist in you.  

Inform your physician if you are allergic to Irnocam 100mg Injection and its ingredients. Before starting treatment, let your physician know if you have liver problems or jaundice, kidney and heart problems, asthma, high blood pressure or high cholesterol, or severe diarrhea. If you are smoking or have ever received radiation therapy, report to your healthcare provider. Consult your healthcare provider if you take other medicines, herbs, and supplements. Effective contraception (birth control) by males and females during treatment is important to avoid pregnancy. Your physician will perform blood tests during and before treatment to check for the effects of the medicine on blood counts or blood chemistry.

Uses of Irnocam 100mg Injection

Treatment of metastatic cancer of the colon and rectum (large intestine).

 

More Information

• Do not freeze.
• Store protected from light at a temperature not exceeding 25°C.
• Keep this medicine away from the sight and reach of children.

Safety Advices Pregnancy

Irnocam 100mg Injection is unsafe to use during pregnancy as it may harm the developing baby. Women who have potential childbearing use effective contraceptives during and after 6 months after treatment.   

Breast Feeding

It is unsafe to use during breastfeeding as Irnocam 100mg Injection and its metabolites are found in human milk. It must be discontinued for the duration of therapy. Consult your doctor for advice.  

Lungs

It is unknown whether it is safe to administer Irnocam 100mg Injection in patients with lung disorders. Please consult your doctor for more advice.  

Liver

Irnocam 100mg Injection is used with caution in patients with liver impairment. Inform your physician before starting treatment if you have liver disease or jaundice. Your physician will monitor your liver functions and adjust the dose accordingly.  

Alcohol

It is unknown whether it is safe to drink alcohol while taking Irnocam 100mg Injection. Check with your doctor for advice.  

Driving

You may feel dizzy or tired for 24 hours after taking this medicine. Do not use any tools or drive during treatment with Irnocam 100mg Injection. 

Side Effects

• Early and late diarrhea
• Allergic reactions
• Kidney impairment
• Lung problems
• Low levels of RBC, WBC, and platelets in the blood

• Nausea, vomiting, abdominal pain
• Constipation
• Diarrhea
• Anemia
• Pain
• Fatigue
• Fever, infections including sepsis
• Abnormal bilirubin levels
• Hair loss
• Weight loss

Treatment Type	Lymphobalstic Leukemia
Strength	10000 iu
Formulation Type	Lyophillized
Brand	Leucoginase
Packaging Type	Vial
Manufacturer	VHB
Form	Injection
Storage Temperature	2-8 degree c
Shelf Life	24 months
Dosage Form	Injection
Storage Condition	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Leucoginase 10000IU Injection contains L-asparaginase. It is used to treat Acute Lymphoblastic Leukemia (cancer of white blood cells) in patients aged four months and above. In Acute Lymphoblastic Leukemia, the white blood cells called lymphocytes multiply in an uncontrolled and abnormal manner. This disorder is also known as Acute Lymphocytic Leukemia. 

This medicine should not be used if you have severe problems with your pancreas or allergic to any of the ingredients of this medicine. Talk to your physician if you are a diabetic patient as this medicine contains glucose. The common side effects of Leucoginase 10000IU Injection are muscle pain, nausea, infections, abdominal pain, and diarrhea.  

Use effective birth control during the treatment with Leucoginase 10000IU Injection and for at least three months after the last dose. Women should use contraception methods other than oral contraceptives.

Uses of Leucoginase 10000iu Injection

• Acute Lymphoblastic Leukemia (ALL)

Therapeutic Effects of Leucoginase 10000iu Injection

Cancer cells need a substance called asparagine to survive. Leucoginase  10000IU Injection works by lowering the levels of asparagine in the body.

Interaction of Leucoginase 10000iu Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products that  you are taking or have taken before the treatment. Certain medications may interact with Leucoginase 10000IU injection and can cause undesirable side effects.

More Information about Leucoginase 10000iu Injection

• Keep Leucoginase 10000IU Injection out of sight and reach of children.
• Store in a refrigerator (2°C to 8°C).

How to consume Leucoginase 10000iu Injection

It will be given to you by your health care professional. Do not self-administer. Your physician will decide the dose and duration of your treatment based on the disease severity and other factors.

Safety Advices for Leucoginase 10000iu Injection   Pregnancy

You need to tell your physician if you are pregnant or planning to get pregnant before taking Leucoginase 10000IU  Injection. it will be given to you if clearly needed.  

Breast Feeding  

You must not breastfeed your baby during treatment with Leucoginase 10000IU Injection. You need to tell your physician if you are breastfeeding before taking this medicine.  

Lungs  

You need to tell your physician if you have any lung disorders before taking Leucoginase 10000IU Injection.  

Liver  

You must tell your physician if you have any liver disorders before taking Leucoginase 10000IU Injection.  

Alcohol  

It is not known whether it is safe to consume alcohol with Leucoginase 10000IU Injection. Please consult your doctor.  

Driving  

Leucoginase 10000IU Injection can cause dizziness and drowsiness. Avoid driving if you are unwell.

Side Effects

• Severe allergic reactions
• High blood sugar levels
• Bleeding
• Liver and nervous problems
• Pain near your stomach (inflammation of the pancreas)
• Blood clots in arm or leg
• Pain, bruising, swelling, or hardening of the skin at the injection site

• Nausea
• Muscle pain
• Weight loss
• Infections (fever, rapid heart rate, confusion, or a rash)
• Difficulty breathing
• Inflammation of the digestive tract
• Diarrhea
• Abdominal pain, discomfort
• Headache
• Tiredness

Strength	200 mg
Pack Size	60 tablets
Brand	Lucaparib
Composition	Rucaparib 200 mg
Indication	Ovarian Cancer
Prescription Type	Rx Only
Storage Condition	Store at 20 DegreeC to 25 DegreeC
Prescription/Non prescription	Prescription
Form	Tablet
Country of Origin	Made in India

Lucaparib 200mg tablet contains the active ingredient rucaparib. It is an anti-cancer medicine that belongs to the class of medications called PARP (poly ADP-ribose polymerase) inhibitors. It is used to help maintain the response to other treatments for certain types of ovarian cancer, fallopian tube (a tube that transports eggs released by the ovaries to the uterus), and primary peritoneal (layer of tissue that lines the abdomen) cancer that has reoccurred in adults who have previously completely responded or partially responded to other chemotherapy treatments. 

It is also used to treat certain types of cancer in people with specific gene (BRCA) changes who have received treatment with at least two other chemotherapy treatments. It is also indicated as maintenance therapy immediately after chemotherapy which has caused the tumor to shrink. Do not take Lucaparib 200mg tablet if you are allergic to Lucaparib or any of the ingredients. This medication can cause low blood counts; hence your healthcare professional will advise you to take certain blood tests before and every month during the treatment.  

Inform your doctor if you have nausea, vomiting, diarrhea, or abdominal pain during the treatment because this medicine may affect your stomach or bowels. Lucaparib 200mg tablet should not be given to children under 18 years of age. Notify your physician if you are pregnant, breastfeeding, suspecting, or planning for pregnancy during the treatment with this medicine. Women with reproductive potential should use effective contraception during the treatment.

Uses of Lucaparib 200mg Tablet

• Ovarian cancer
• Fallopian tube cancer
• Primary peritoneal cancer
• Prostate cancer

 

More Information

• Store at 20°C to 25°C
• Protect the medicine from light and excessive moisture.
• Keep the medicine out of reach of children and pets
• If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.

Safety Advices Pregnancy  

Do not take Lucaparib 200mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 6 months after the last dose. Lucaparib   

Breast Feeding  

Breastfeeding is not recommended in patients taking Lucaparib 200mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.   

Lungs  

It is unknown whether Lucaparib 200mg tablet is safe to be administer in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.   

Liver  

Lucaparib 200mg tablet is safe when administered in patients with liver disease. No dose adjustments are necessary.   

Alcohol  

It is not known whether it is safe to consume alcohol with Lucaparib 200mg tablet. Please consult your doctor.  

Driving  

Lucaparib 200mg tablet may cause dizziness and drowsiness. Driving or operating heavy machinery is unsafe if you experience any symptoms that affect your ability to concentrate and react.

Side Effects

• Rash
• Constipation
• Decrease in appetite
• Diarrhea, indigestion
• Nausea, vomiting
• Changes in the blood count
• Shortness of breath
• Tiredness

• Severe anemia
• Hypersensitivity reactions
• Sepsis (blood infection)
• Pneumonia

Strength	300 mg
Pack Size	60 tablets
Brand	Lucaparib
Composition	Rucaparib 300 mg
Indication	Ovarian Cancer
Prescription Type	Rx Only
Storage Condition	Store at 20 DegreeC to 25 DegreeC
Prescription/Non prescription	Prescription
Form	Tablet
Country of Origin	Made in India

Lucaparib 300mg tablet contains the active ingredient rucaparib. It is an anti-cancer medicine that belongs to the class of medications called PARP (poly ADP-ribose polymerase) inhibitors. It is used to help maintain the response to other treatments for certain types of ovarian cancer, fallopian tube (a tube that transports eggs released by the ovaries to the uterus), and primary peritoneal (layer of tissue that lines the abdomen) cancer that has reoccurred in adults who have previously completely responded or partially responded to other chemotherapy treatments. 

It is also used to treat certain types of cancer in people with specific gene (BRCA) changes who have received treatment with at least two other chemotherapy treatments. It is also indicated as maintenance therapy immediately after chemotherapy which has caused the tumor to shrink. Do not take Lucaparib 300mg tablet if you are allergic to Lucaparib or any of the ingredients. This medication can cause low blood counts; hence your healthcare professional will advise you to take certain blood tests before and every month during the treatment.  

Inform your doctor if you have nausea, vomiting, diarrhea, or abdominal pain during the treatment because this medicine may affect your stomach or bowels. Lucaparib 300mg tablet should not be given to children under 18 years of age. Notify your physician if you are pregnant, breastfeeding, suspecting, or planning for pregnancy during the treatment with this medicine. Women with reproductive potential should use effective contraception during the treatment.

Uses of Lucaparib 300mg Tablet

• Ovarian cancer
• Fallopian tube cancer
• Primary peritoneal cancer
• Prostate cancer

 

More Information

• Store at 20°C to 25°C
• Protect the medicine from light and excessive moisture.
• Keep the medicine out of reach of children and pets
• If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.

Safety Advices  Pregnancy  

Do not take Lucaparib 300mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 6 months after the last dose. Lucaparib   

Breast Feeding  

Breastfeeding is not recommended in patients taking Lucaparib 300mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.   

Lungs  

It is unknown whether Lucaparib 300mg tablet is safe to be administer in patients with lung diseases. Inform your physician if you have any lung diseases before initiating the therapy.  

Liver  

Lucaparib 300mg tablet is safe when administered in patients with liver disease. No dose adjustments are necessary.   

Alcohol  

It is not known whether it is safe to consume alcohol with Lucaparib 300mg tablet. Please consult your doctor.  

Driving  

Lucaparib 300mg tablet may cause dizziness and drowsiness. Driving or operating heavy machinery is unsafe if you experience any symptoms that affect your ability to concentrate and react.

Side Effects

• Rash
• Constipation
• Decrease in appetite
• Diarrhea, indigestion
• Nausea, vomiting
• Changes in the blood count
• Shortness of breath
• Tiredness

• Severe anemia
• Hypersensitivity reactions
• Sepsis (blood infection)
• Pneumonia

Strength	100 mg/5 ml
Vial Volume	5 ml
Strength per ml	5 mg/ml
Brand	Rinotec
Composition	Irinotecan HCl Trihydrate
Packaging Type	Vial
Storage Condition	Store protected from light at a temperature not exceeding 25 DegreeC.
Manufacturer	UNITED BIOTECH PVT LTD
Prescription/Non prescription	Prescription
Form	Injection
Shelf Life	24 months
Indication	Colorectal Cancer
Country of Origin	Made in India

Rinotec 100mg Injection belongs to the group of medications called anti-cancer medicines or cytostatics. It consists of the active ingredient Irinotecan hydrochloride trihydrate. It is indicated for advanced colon cancer and rectal cancer in adults. It is prescribed alone or in combination with other chemotherapeutic agents. Cancer in the colon and rectum is prevalent in age groups above 50 and is further triggered by genetic and environmental factors.  

Myelosuppression (bone marrow suppression leading to low levels of RBC, WBC, and platelets in the blood) and diarrhea are the most common adverse effects of this medication. Other common side effects of Rinotec 100mg Injection are nausea, vomiting, abdominal pain, constipation, anemia, pain, fatigue, fever, infections including sepsis, abnormal bilirubin levels, hair loss, and weight loss. Inform your doctor if these side effects disturb or persist in you.  

Inform your physician if you are allergic to Rinotec 100mg Injection and its ingredients. Before starting treatment, let your physician know if you have liver problems or jaundice, kidney and heart problems, asthma, high blood pressure or high cholesterol, or severe diarrhea. If you are smoking or have ever received radiation therapy, report to your healthcare provider. Consult your healthcare provider if you take other medicines, herbs, and supplements. Effective contraception (birth control) by males and females during treatment is important to avoid pregnancy. Your physician will perform blood tests during and before treatment to check for the effects of the medicine on blood counts or blood chemistry.

Uses of Rinotec 100mg Injection

Treatment of metastatic cancer of the colon and rectum (large intestine).

 

More Information

• Do not freeze.
• Store protected from light at a temperature not exceeding 25°C.
• Keep this medicine away from the sight and reach of children.

Safety Advices Pregnancy  

Rinotec 100mg Injection is unsafe to use during pregnancy as it may harm the developing baby. Women who have potential childbearing use effective contraceptives during and after 6 months after treatment.   

Breast Feeding  

It is unsafe to use during breastfeeding as Rinotec 100mg Injection and its metabolites are found in human milk. It must be discontinued for the duration of therapy. Consult your doctor for advice.  

Lungs

It is unknown whether it is safe to administer Rinotec 100mg Injection in patients with lung disorders. Please consult your doctor for more advice.  

Liver  

Rinotec 100mg Injection is used with caution in patients with liver impairment. Inform your physician before starting treatment if you have liver disease or jaundice. Your physician will monitor your liver functions and adjust the dose accordingly.  

Alcohol  

It is unknown whether it is safe to drink alcohol while taking Rinotec 100mg Injection. Check with your doctor for advice.  

Driving  

You may feel dizzy or tired for 24 hours after taking this medicine. Do not use any tools or drive during treatment with Rinotec 100mg Injection. 

Side Effects

• Early and late diarrhea
• Allergic reactions
• Kidney impairment
• Lung problems
• Low levels of RBC, WBC, and platelets in the blood

• Nausea, vomiting, abdominal pain
• Constipation
• Diarrhea
• Anemia
• Pain
• Fatigue
• Fever, infections including sepsis
• Abnormal bilirubin levels
• Hair loss
• Weight loss

Strength	450 mg
Packaging Size	1*10 Tablets
Brand	Virolfi
Pack Size	10 tablets
Dose Form	Tablet
Manufacturer	ZYDUS CADILA
Indication	CMV retinitis
Composition	Valganciclovir 450mg
Treatment	Treatment and prevention of Cytomegalovirus (CMV) infection
Prescription/Non prescription	Prescription
Usage / Application	Personal
Packaging Type	Stripe
Shelf Life	24 months
Also gives	PCD Pharma

Virolfi 450mg tablet is an Antiviral with an active ingredient called Valganciclovir. It belongs to the medication group known as Antiviral (Non-HIV) drugs. Valganciclovir is converted into Ganciclovir after entering the body, which acts to fight viral infections. It is used to treat Cytomegalovirus (CMV) infections of the retina of the eye in adults with Acquired immune deficiency syndrome (AIDS). Cytomegalovirus infection often leads to vision problems and blindness. Additionally, it prevents Cytomegalovirus (CMV) infections in patients who received an organ transplant from a person infected with CMV in adults and children.  

Do not take this drug if you are allergic to Valganciclovir, Ganciclovir, and its other ingredients. Inform your physician if you have a lower blood cell count ( WBC, RBC, Platelet). Notify your doctor if you took any radiotherapy or hemodialysis (a treatment to filter wastes and water from your blood) or conditions with your kidney. Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after the treatment; women should use contraception for 30 days, whereas men should use condoms for 90 days during and after the treatment.

Uses

• Treatment and prevention of Cytomegalovirus (CMV) infection

More Information

• Keep out of sight and reach of pets and children
• Store at room temperature between 15°C to 30°C.
• Do not freeze.

Safety Advices Pregnancy  

Taking Virolfi 450mg tablet while pregnant can harm the baby. You should not take this medicine during the pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to get pregnant before taking this medicine. Use effective contraception to avoid pregnancy.  

Breast Feeding  

Taking Virolfi 450mg tablet while breastfeeding may be unsafe because it may affect the child. Talk to your physician to get more information.   

Lungs  

It is unknown whether Virolfi 450mg tablet  is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

It is unknown whether Virolfi 450mg tablet is safe to administer in patients with liver problems. Inform your physician if you have any liver disease before starting the treatment. Contact your doctor if you experience any liver-related symptoms.  

Alcohol  

It is unknown whether consuming alcohol while taking a Virolfi 450mg tablet is safe. Please speak with your physician.  

Driving  

While taking Virolfi 450mg tablet , it is unsafe to drive or use machines because it may cause dizziness, shaky, changes in vision, etc. Talk to your doctor for more information. 

Side Effects

• Anaphylactic shock (sudden swelling of the throat, face, lips, hand, ankles, difficulty swallowing, itchy skin rash)
• Low blood counts (shortness of breath, pale skin, mouth ulcers, sore throat)
• Blood infection
• Severe stomach pain which spreads into your back
• Seizures

• Respiratory tract infections
• Loss of appetite
• Headache, Dizziness
• Cough, fever
• Diarrhea, constipation
• Tiredness, feeling sick
• Infections in the urinary tract, skin
• Weight loss
• Anxious, confused, depression
• Troubled sleeping
• Abnormal sensation of skin (tickling, pricking, burning, tingling)
• Changes in taste
• Eye, ear pain
• Night sweats
• Joint pain, muscle spasms
• Hair loss
• Low blood pressure

Strength	250 mg
Packaging Size	30 Tablets
Composition	Lapatinib
Pack Size	30 Tablets
Brand	Herlapsa
Form	Tablet
Usage	Breast Cancer
Storage Condition	Store below 30 DegreeC and away from light.
Manufactured By	MYLAN PHARMACEUTICALS PVT LTD
Prescription/Non Prescription	Prescription
Country of Origin	Made in India

Herlapsa 250mg Tablet contains the active ingredient lapatinib. It is indicated to treat advanced breast cancer and it may be used alone or in combination with other medications. It is effective against cells sensitive to hormones and rapidly multiplying cancer cells that produce most of the protein called human epidermal growth receptor -2.

The common side effects that are likely to occur while you are on the treatment with Herlapsa 250mg Tablet are nausea, vomiting, tiredness, weakness, itching, dry skin, loss of appetite, indigestion, constipation, mouth ulcers, stomach pain, difficulty in sleeping, joint or back pain, cough, breathing problems, headache, etc. If you experience severe allergic reactions, skin rashes, heart, liver, and lung problems, report your physician immediately.

Inform your healthcare provider at the first sign of diarrhea or dehydration. Monitor your blood pressure regularly while taking Herlapsa 250mg Tablet. If you have diarrhea while taking this medication, drink plenty of fluids, eat low-fat, high-protein foods, and avoid milk and its products and herbal supplements.

Uses of Herlapsa 250mg Tablet

• Treats advanced or HER2 Positive metastatic breast cancer.

Therapeutic Effects of Herlapsa 250mg Tablet

Herlapsa 250mg Tablet acts against the enzyme called tyrosine kinase. It prevents the Human epidermal growth factor receptor protein (HER2) and Epidermal growth factor receptors (EGFRs) from signaling, which are produced by breast cancer cells. It kills cancer cells and slows down their growth. 

Interaction of Herlapsa 250mg Tablet with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Herlapsa 250mg Tablet Injection and cause undesirable side effects.

More Information about Herlapsa 250mg Tablet

• Store below 30°C and away from light.

Safety Advices Pregnancy  

It is not safe to consume Herlapsa 250mg Tablet while you are pregnant. Consult your doctor and use a reliable contraception method to avoid becoming pregnant during this treatment.  

Breast Feeding  

Herlapsa 250mg Tablet is unsafe during breastfeeding as this medication tends to pass into the breast milk and affect the baby.  

Lungs  

Talk to your doctor if you have any lung conditions before starting treatment with Herlapsa 250mg Tablet.  

Liver  

Herlapsa 250mg Tablet should be used with caution in patients with severe liver disease. Consult your physician for advice.  

Alcohol  

Avoid drinking alcohol while taking Herlapsa 250mg Tablet as it may cause dizziness.  

Driving  

Herlapsa  250mg Tablet may affect your ability to drive or perform activities that require focus. Exercise caution while driving or using machines.

Side Effects

• Diarrhea
• Severe allergic reactions
• Skin rash
• Heart problems

• Loss of appetite
• Nausea, vomiting
• Tiredness, weakness
• Indigestion
• Constipation
• Sore mouth or mouth ulcers
• Stomach pain
• Trouble sleeping
• Back pain
• Pain in the hands and feet
• Joint or back pain
• Cough, breathlessness
• Headache
• Nose bleed
• Hot flush
• Unusual hair loss
• Dry skin and itching

Strength	100 mg/5 ml
Vial Volume	5 ml
Strength per ml	5 mg/ml
Brand	Irinotel
Composition	Irinotecan HCl Trihydrate
Packaging Type	Vial
Storage Condition	Store protected from light at a temperature not exceeding 25 DegreeC.
Manufacturer	FRESENIUS KABI INDIA PVT LTD
Prescription/Non prescription	Prescription
Form	Injection
Shelf Life	24 months
Indication	Colorectal Cancer
Country of Origin	Made in India

Irinotel 100mg Injection belongs to the group of medications called anti-cancer medicines or cytostatics. It consists of the active ingredient Irinotecan hydrochloride trihydrate. It is indicated for advanced colon cancer and rectal cancer in adults. It is prescribed alone or in combination with other chemotherapeutic agents. Cancer in the colon and rectum is prevalent in age groups above 50 and is further triggered by genetic and environmental factors.  

Myelosuppression (bone marrow suppression leading to low levels of RBC, WBC, and platelets in the blood) and diarrhea are the most common adverse effects of this medication. Other common side effects of Irinotel 100mg Injection are nausea, vomiting, abdominal pain, constipation, anemia, pain, fatigue, fever, infections including sepsis, abnormal bilirubin levels, hair loss, and weight loss. Inform your doctor if these side effects disturb or persist in you.  

Inform your physician if you are allergic to Irinotel 100mg Injection and its ingredients. Before starting treatment, let your physician know if you have liver problems or jaundice, kidney and heart problems, asthma, high blood pressure or high cholesterol, or severe diarrhea. If you are smoking or have ever received radiation therapy, report to your healthcare provider. Consult your healthcare provider if you take other medicines, herbs, and supplements. Effective contraception (birth control) by males and females during treatment is important to avoid pregnancy. Your physician will perform blood tests during and before treatment to check for the effects of the medicine on blood counts or blood chemistry.

Uses of Irinotel 100mg Injection

Treatment of metastatic cancer of the colon and rectum (large intestine).

 

More Information

• Do not freeze.
• Store protected from light at a temperature not exceeding 25°C.
• Keep this medicine away from the sight and reach of children.

Safety Advices Pregnancy  

Irinotel 100mg Injection is unsafe to use during pregnancy as it may harm the developing baby. Women who have potential childbearing use effective contraceptives during and after 6 months after treatment.   

Breast Feeding  

It is unsafe to use during breastfeeding as Irinotel 100mg Injection and its metabolites are found in human milk. It must be discontinued for the duration of therapy. Consult your doctor for advice.  

Lungs  

It is unknown whether it is safe to administer Irinotel 100mg Injection in patients with lung disorders. Please consult your doctor for more advice.  

Liver  

Irinotel 100mg Injection is used with caution in patients with liver impairment. Inform your physician before starting treatment if you have liver disease or jaundice. Your physician will monitor your liver functions and adjust the dose accordingly.  

Alcohol  

It is unknown whether it is safe to drink alcohol while taking Irinotel 100mg Injection. Check with your doctor for advice.  

Driving  

You may feel dizzy or tired for 24 hours after taking this medicine. Do not use any tools or drive during treatment with Irinotel 100mg Injection. 

Side Effects

• Early and late diarrhea
• Allergic reactions
• Kidney impairment
• Lung problems
• Low levels of RBC, WBC, and platelets in the blood

• Nausea, vomiting, abdominal pain
• Constipation
• Diarrhea
• Anemia
• Pain
• Fatigue
• Fever, infections including sepsis
• Abnormal bilirubin levels
• Hair loss
• Weight loss

Strength	450 mg
Packaging Size	1*10 Tablets
Brand	Valcip
Pack Size	10 tablets
Dose Form	Tablet
Manufacturer	CIPLA LTD
Indication	CMV retinitis
Composition	Valganciclovir 450mg
Treatment	Treatment and prevention of Cytomegalovirus (CMV) infection
Prescription/Non prescription	Prescription
Usage / Application	Personal
Packaging Type	Stripe
Shelf Life	24 months
Also gives	PCD Pharma

Valcip 450mg tablet is an Antiviral with an active ingredient called Valganciclovir. It belongs to the medication group known as Antiviral (Non-HIV) drugs. Valganciclovir is converted into Ganciclovir after entering the body, which acts to fight viral infections. It is used to treat Cytomegalovirus (CMV) infections of the retina of the eye in adults with Acquired immune deficiency syndrome (AIDS). Cytomegalovirus infection often leads to vision problems and blindness. Additionally, it prevents Cytomegalovirus (CMV) infections in patients who received an organ transplant from a person infected with CMV in adults and children.  

Do not take this drug if you are allergic to Valganciclovir, Ganciclovir, and its other ingredients. Inform your physician if you have a lower blood cell count ( WBC, RBC, Platelet). Notify your doctor if you took any radiotherapy or hemodialysis (a treatment to filter wastes and water from your blood) or conditions with your kidney. Inform your physician if you are pregnant or planning to get pregnant. Use effective contraception during and even after the treatment; women should use contraception for 30 days, whereas men should use condoms for 90 days during and after the treatment.

Uses

• Treatment and prevention of Cytomegalovirus (CMV) infection

More Information

• Keep out of sight and reach of pets and children
• Store at room temperature between 15°C to 30°C.
• Do not freeze.

Safety Advices Pregnancy  

Taking Valcip 450mg tablet while pregnant can harm the baby. You should not take this medicine during the pregnancy unless your doctor recommends taking it. Inform your doctor if you are pregnant or planning to get pregnant before taking this medicine. Use effective contraception to avoid pregnancy.  

Breast Feeding  

Taking Valcip 450mg tablet while breastfeeding may be unsafe because it may affect the child. Talk to your physician to get more information.   

Lungs  

It is unknown whether Valcip 450mg tablet  is safe to administer in patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.  

Liver  

It is unknown whether Valcip 450mg tablet is safe to administer in patients with liver problems. Inform your physician if you have any liver disease before starting the treatment. Contact your doctor if you experience any liver-related symptoms.  

Alcohol  

It is unknown whether consuming alcohol while taking a Valcip 450mg tablet is safe. Please speak with your physician.  

Driving  

While taking Valcip 450mg tablet , it is unsafe to drive or use machines because it may cause dizziness, shaky, changes in vision, etc. Talk to your doctor for more information. 

Side Effects

• Anaphylactic shock (sudden swelling of the throat, face, lips, hand, ankles, difficulty swallowing, itchy skin rash)
• Low blood counts (shortness of breath, pale skin, mouth ulcers, sore throat)
• Blood infection
• Severe stomach pain which spreads into your back
• Seizures

• Respiratory tract infections
• Loss of appetite
• Headache, Dizziness
• Cough, fever
• Diarrhea, constipation
• Tiredness, feeling sick
• Infections in the urinary tract, skin
• Weight loss
• Anxious, confused, depression
• Troubled sleeping
• Abnormal sensation of skin (tickling, pricking, burning, tingling)
• Changes in taste
• Eye, ear pain
• Night sweats
• Joint pain, muscle spasms
• Hair loss
• Low blood pressure

Strength	50 mg
Vial Volume	2 ml
Brand	Emmdara
Route	IV Infusion
Form	Injection
Composition	Fludarabine Phosphate
Packaging Type	Vial
Storage Condition	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Prescription/Non prescription	Prescription
Shelf Life	24 Months
Usage	Personal
Storage Conditions	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Manufacturer	Emcure Pharmaceuticals Ltd

Emmdara 50mg Injection is a chemotherapy medication containing the active ingredient fludarabine. It is used to treat B-cell chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia is cancer of white blood cells (disease-fighting agents) in which the body produces many abnormal white blood cells, and lymph nodes start to grow in various parts of the body. This can lead to organ failure, decrease in red blood cells, severe bleeding and infections.

Emmdara 50mg Injection is not recommended for adolescents and children under 18 years of age, breastfeeding patients, and patients with severe kidney problems or low red blood cell count. Use effective birth control methods during the treatment with this medicine and for at least six months from the last dose. Avoid live vaccination while taking this medicine. Report to your doctor if you experience any allergic reactions while taking Emmdara 50mg Injection.

Uses of Emmdara 50mg Injection

• Treatment of B-Cell chronic lymphocytic leukemia (blood cancer)

Therapeutic Effects of Emmdara 50mg Injection

Emmdara 50mg Injection works by decreasing or stopping the growth of cancer cells by inhibiting the DNA synthesis in cancer cells.

Interaction of Emmdara 50mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Emmdara 50mg Injection and cause undesirable side effects.

More Information about Emmdara 50mg Injection

• Keep Emmdara 50mg Injection out of sight and reach of children.
• Store in a refrigerator (2°C to 8°C).

How to consume Emmdara 50mg Injection

This injection should not be self administered and it should be taken only under the supervision of the doctors or nurse. Dosage of this injection will differ depending upon the patient’s age and severity of the condition.

Safety Advices   Pregnancy  

Emmdara 50mg Injection is not recommended for use in pregnancy. Your doctor will prescribe the medication if the benefits outweigh the risks.  

Breast Feeding  

Breastfeeding is not recommended during treatment with Emmdara 50mg Injection. Consult your doctor for advice  

Lungs  

Talk to your doctor if you have any lung conditions before starting treatment with Emmdara 50mg Injection.   

Liver  

It is essential to inform your doctor if you have any liver disorders before taking this medicine.  

Alcohol  

Consult your doctor regarding advice on alcohol consumption before starting treatment with Emmdara 50mg Injection.   

Driving  

Emmdara 50mg Injection may cause tiredness or disturbed vision. Avoid driving if you are unwell.

Side Effects

• Lung infection (cough, chest pain, difficulty breathing)
• Unusual bleeding or bruising
• Blood in urine, reduced amount of urine, or pain in your side
• Skin reactions (redness, inflammation, or blistering)
• Palpitations

• Diarrhea
• Fever
• Weakness, tiredness
• Nausea, vomiting
• Low blood count
• Infections

Strength	50 mg
Vial Volume	2 ml
Brand	Fludocyte
Route	IV Infusion
Form	Injection
Composition	Fludarabine Phosphate
Packaging Type	Vial
Storage Condition	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Prescription/Non prescription	Prescription
Shelf Life	24 Months
Usage	Personal
Storage Conditions	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Manufacturer	INTAS PHARMACEUTICALS LTD

Fludocyte 50mg Injection is a chemotherapy medication containing the active ingredient fludarabine. It is used to treat B-cell chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia is cancer of white blood cells (disease-fighting agents) in which the body produces many abnormal white blood cells, and lymph nodes start to grow in various parts of the body. This can lead to organ failure, decrease in red blood cells, severe bleeding and infections.

Fludocyte 50mg Injection is not recommended for adolescents and children under 18 years of age, breastfeeding patients, and patients with severe kidney problems or low red blood cell count. Use effective birth control methods during the treatment with this medicine and for at least six months from the last dose. Avoid live vaccination while taking this medicine. Report to your doctor if you experience any allergic reactions while taking Fludocyte 50mg Injection.

Uses of Fludocyte 50mg Injection

• Treatment of B-Cell chronic lymphocytic leukemia (blood cancer)

Therapeutic Effects of Fludocyte 50mg Injection

Fludocyte 50mg Injection works by decreasing or stopping the growth of cancer cells by inhibiting the DNA synthesis in cancer cells.

Interaction of Fludocyte 50mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Fludocyte 50mg Injection and cause undesirable side effects.

More Information about Fludocyte 50mg Injection

• Keep Fludocyte 50mg Injection out of sight and reach of children.
• Store in a refrigerator (2°C to 8°C).

How to consume Fludocyte 50mg Injection

This injection should not be self administered and it should be taken only under the supervision of the doctors or nurse. Dosage of this injection will differ depending upon the patient’s age and severity of the condition.

Safety Advices Pregnancy  

Fludocyte 50mg Injection is not recommended for use in pregnancy. Your doctor will prescribe the medication if the benefits outweigh the risks.  

Breast Feeding  

Breastfeeding is not recommended during treatment with Fludocyte 50mg Injection. Consult your doctor for advice  

Lungs  

Talk to your doctor if you have any lung conditions before starting treatment with Fludocyte 50mg Injection.   

Liver  

It is essential to inform your doctor if you have any liver disorders before taking this medicine.  

Alcohol  

Consult your doctor regarding advice on alcohol consumption before starting treatment with Fludocyte 50mg Injection.   

Driving  

Fludocyte 50mg Injection may cause tiredness or disturbed vision. Avoid driving if you are unwell.

Side Effects

• Lung infection (cough, chest pain, difficulty breathing)
• Unusual bleeding or bruising
• Blood in urine, reduced amount of urine, or pain in your side
• Skin reactions (redness, inflammation, or blistering)
• Palpitations

• Diarrhea
• Fever
• Weakness, tiredness
• Nausea, vomiting
• Low blood count
• Infections

Strength	2 g
Brand	Ifomid-M
Dose	2 g
Packaging Type	Vial
Physical Form	Solution
Route of Administration	Intravenous
Manufacturer	UNITED BIOTECH PVT LTD
Also gives	PCD Pharma Franchise
Country of Origin	Made in India

Ifomid-M 2gm injection is an anticancer and cytoprotective drug belonging to the category of alkylating agents and hemorrhagic cystitis inhibitors, containing the active ingredient Ifosfamide and Mesna. These drugs are indicated for the treatment of bladder inflammation and cancers in the soft tissues, germ cells, pancreas, and cervix. Mesna mainly protects against some of the harmful effects of certain chemotherapy medications. If you had an allergic reaction to this drug or any of its components, it should not be used. This medicine may cause severe bone marrow suppression which results in low white blood cell count or low platelet count due to chemotherapy or radiation therapy. You should wait for three months before starting the treatment with this drug if you have received a live virus vaccine such as measles, mumps, rubella, or chickenpox. It is advised to use this drug with caution in severe kidney or liver-diseased individuals. Talk to your doctor if you take any other medications or before using over-the-counter medicines or herbal products. Your doctor will evaluate the risk of interaction with this medication.Consult your doctor before using this medication if you are pregnant or plan to have a baby. Ifomid-M 2gm injection is unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this drug. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Breastfeeding should be avoided during the treatment with this drug as it may pass into breast milk in small amounts.Uses of Ifomid-M 2gm Injection Hemorrhagic cystitis (bladder inflammation)Soft tissue cancerGerm cell cancerPancreatic cancerCervical cancerMore Information Store Ifomid-M 2gm injection in a refrigerator (20°C to 25°C).Do not freeze.Keep it out of reach from children.Safety Advices Pregnancy  Ifomid-M 2gm injection is unsafe for pregnant women as it may harm the unborn baby. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant.  Breast Feeding  Ifomid-M 2gm injection is not recommended in breastfeeding women as it may pass into the breast milk.  Lungs  It is unknown whether Ifomid-M 2gm injection can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  Liver  It is unknown whether Ifomid-M 2gm injection can be used for patients with liver disorders. Consult your doctor if you have any liver diseases before starting the treatment.  Alcohol  It is unknown whether consuming alcohol interacts with the Ifomid-M 2gm injection. Please consult your doctor for more advice.  Driving  It is unsafe to drive vehicles or operate heavy machinery after taking the Ifomid-M 2gm injection.Side Effects Immune system suppressionLow levels of RBC, WBC, and platelets in the bloodBone marrow suppressionNerve toxicityUrinary problemsLung problemsKidney problemRashHypersensitivity reactionsHair lossFeverPhlebitisLiver toxicityInfections

Strength	50 mg
Vial Volume	2 ml
Brand	Fludabine
Route	IV Infusion
Form	Injection
Composition	Fludarabine Phosphate
Packaging Type	Vial
Storage Condition	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Prescription/Non prescription	Prescription
Shelf Life	24 Months
Usage	Personal
Storage Conditions	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Manufacturer	United Biotech Pvt Ltd

Fludabine 50mg Injection is a chemotherapy medication containing the active ingredient fludarabine. It is used to treat B-cell chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia is cancer of white blood cells (disease-fighting agents) in which the body produces many abnormal white blood cells, and lymph nodes start to grow in various parts of the body. This can lead to organ failure, decrease in red blood cells, severe bleeding and infections.

Fludabine 50mg Injection is not recommended for adolescents and children under 18 years of age, breastfeeding patients, and patients with severe kidney problems or low red blood cell count. Use effective birth control methods during the treatment with this medicine and for at least six months from the last dose. Avoid live vaccination while taking this medicine. Report to your doctor if you experience any allergic reactions while taking Fludabine 50mg Injection.

Uses of Fludabine 50mg Injection

• Treatment of B-Cell chronic lymphocytic leukemia (blood cancer)

Therapeutic Effects of Fludabine 50mg Injection

Fludabine 50mg Injection works by decreasing or stopping the growth of cancer cells by inhibiting the DNA synthesis in cancer cells.

Interaction of Fludabine 50mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Fludabine 50mg Injection and cause undesirable side effects.

More Information about Fludabine 50mg Injection

• Keep Fludabine 50mg Injection out of sight and reach of children.
• Store in a refrigerator (2°C to 8°C).

How to consume Fludabine 50mg Injection

This injection should not be self administered and it should be taken only under the supervision of the doctors or nurse. Dosage of this injection will differ depending upon the patient’s age and severity of the condition.

Safety Advices Pregnancy  

Fludabine 50mg Injection is not recommended for use in pregnancy. Your doctor will prescribe the medication if the benefits outweigh the risks.  

Breast Feeding  

Breastfeeding is not recommended during treatment with Fludabine 50mg Injection. Consult your doctor for advice  

Lungs  

Talk to your doctor if you have any lung conditions before starting treatment with Fludabine 50mg Injection.   

Liver  

It is essential to inform your doctor if you have any liver disorders before taking this medicine.  

Alcohol  

Consult your doctor regarding advice on alcohol consumption before starting treatment with Fludabine 50mg Injection.   

Driving  

Fludabine 50mg Injection may cause tiredness or disturbed vision. Avoid driving if you are unwell.

Side Effects

• Lung infection (cough, chest pain, difficulty breathing)
• Unusual bleeding or bruising
• Blood in urine, reduced amount of urine, or pain in your side
• Skin reactions (redness, inflammation, or blistering)
• Palpitations

• Diarrhea
• Fever
• Weakness, tiredness
• Nausea, vomiting
• Low blood count
• Infections

Strength	50 mg
Vial Volume	2 ml
Brand	Fludacel
Route	IV Infusion
Form	Injection
Composition	Fludarabine Phosphate
Packaging Type	Vial
Storage Condition	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Prescription/Non prescription	Prescription
Shelf Life	24 months
Usage	Personal
Storage Conditions	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Manufacturer	CELON LABORATORIES LTD

Fludacel 50mg Injection is a chemotherapy medication containing the active ingredient fludarabine. It is used to treat B-cell chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia is cancer of white blood cells (disease-fighting agents) in which the body produces many abnormal white blood cells, and lymph nodes start to grow in various parts of the body. This can lead to organ failure, decrease in red blood cells, severe bleeding and infections.

Fludacel 50mg Injection is not recommended for adolescents and children under 18 years of age, breastfeeding patients, and patients with severe kidney problems or low red blood cell count. Use effective birth control methods during the treatment with this medicine and for at least six months from the last dose. Avoid live vaccination while taking this medicine. Report to your doctor if you experience any allergic reactions while taking Fludacel 50mg Injection.

Uses of Fludacel 50mg Injection

• Treatment of B-Cell chronic lymphocytic leukemia (blood cancer)

Therapeutic Effects of Fludacel 50mg Injection

Fludacel 50mg Injection works by decreasing or stopping the growth of cancer cells by inhibiting the DNA synthesis in cancer cells.

Interaction of Fludacel 50mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Fludacel 50mg Injection and cause undesirable side effects.

More Information about Fludacel 50mg Injection

• Keep Fludacel 50mg Injection out of sight and reach of children.
• Store in a refrigerator (2°C to 8°C).

How to consume Fludacel 50mg Injection

This injection should not be self administered and it should be taken only under the supervision of the doctors or nurse. Dosage of this injection will differ depending upon the patient’s age and severity of the condition.

Safety Advices  Pregnancy  

Fludacel 50mg Injection is not recommended for use in pregnancy. Your doctor will prescribe the medication if the benefits outweigh the risks.  

Breast Feeding  

Breastfeeding is not recommended during treatment with Fludacel 50mg Injection. Consult your doctor for advice  

Lungs  

Talk to your doctor if you have any lung conditions before starting treatment with Fludacel 50mg Injection.  

Liver  

It is essential to inform your doctor if you have any liver disorders before taking this medicine.  

Alcohol  

Consult your doctor regarding advice on alcohol consumption before starting treatment with Fludacel 50mg Injection.   

Driving  

Fludacel 50mg Injection may cause tiredness or disturbed vision. Avoid driving if you are unwell.

Side Effects

• Lung infection (cough, chest pain, difficulty breathing)
• Unusual bleeding or bruising
• Blood in urine, reduced amount of urine, or pain in your side
• Skin reactions (redness, inflammation, or blistering)
• Palpitations

• Diarrhea
• Fever
• Weakness, tiredness
• Nausea, vomiting
• Low blood count
• Infections

Strength	50 mg
Vial Volume	2 ml
Brand	Fludarither
Route	IV Infusion
Form	Injection
Composition	Fludarabine Phosphate
Packaging Type	Vial
Storage Condition	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Prescription/Non prescription	Prescription
Shelf Life	24 Months
Usage	Personal
Storage Conditions	Store in a refrigerator (2 DegreeC to 8 DegreeC).
Manufacturer	THERDOSE PHARMA PVT LTD

Fludarither 50mg Injection is a chemotherapy medication containing the active ingredient fludarabine. It is used to treat B-cell chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia is cancer of white blood cells (disease-fighting agents) in which the body produces many abnormal white blood cells, and lymph nodes start to grow in various parts of the body. This can lead to organ failure, decrease in red blood cells, severe bleeding and infections.

Fludarither 50mg Injection is not recommended for adolescents and children under 18 years of age, breastfeeding patients, and patients with severe kidney problems or low red blood cell count. Use effective birth control methods during the treatment with this medicine and for at least six months from the last dose. Avoid live vaccination while taking this medicine. Report to your doctor if you experience any allergic reactions while taking Fludarither 50mg Injection.

Uses of Fludarither 50mg Injection

• Treatment of B-Cell chronic lymphocytic leukemia (blood cancer)

Therapeutic Effects of Fludarither 50mg Injection

Fludarither 50mg Injection works by decreasing or stopping the growth of cancer cells by inhibiting the DNA synthesis in cancer cells.

Interaction of Fludarither 50mg Injection with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Fludarither 50mg Injection and cause undesirable side effects.

More Information about Fludarither 50mg Injection

• Keep Fludarither 50mg Injection out of sight and reach of children.
• Store in a refrigerator (2°C to 8°C).

How to consume Fludarither 50mg Injection

This injection should not be self administered and it should be taken only under the supervision of the doctors or nurse. Dosage of this injection will differ depending upon the patient’s age and severity of the condition.

Safety Advices   Pregnancy  

Fludarither 50mg Injection is not recommended for use in pregnancy. Your doctor will prescribe the medication if the benefits outweigh the risks.  

Breast Feeding  

Breastfeeding is not recommended during treatment with Fludarither 50mg Injection. Consult your doctor for advice  

Lungs  

Talk to your doctor if you have any lung conditions before starting treatment with Fludarither 50mg Injection.   

Liver  

It is essential to inform your doctor if you have any liver disorders before taking this medicine.  

Alcohol  

Consult your doctor regarding advice on alcohol consumption before starting treatment with Fludarither 50mg Injection.   

Driving  

Fludarither 50mg Injection may cause tiredness or disturbed vision. Avoid driving if you are unwell.

Side Effects

• Lung infection (cough, chest pain, difficulty breathing)
• Unusual bleeding or bruising
• Blood in urine, reduced amount of urine, or pain in your side
• Skin reactions (redness, inflammation, or blistering)
• Palpitations

• Diarrhea
• Fever
• Weakness, tiredness
• Nausea, vomiting
• Low blood count
• Infections

Strength	2000 mg
Treatment Type	Breast Cancer
Dosage Form	Injection
Brand	Zydus
Dose	2 g
Packaging Type	Vial
Physical Form	Solution
Route of Administration	Intravenous
Form	Injection
Manufacturer	Zydus
Storage Condition	Store Ifex-M 2gm injection in a refrigerator (20 DegreeC to 25 DegreeC).
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Ifex-M 2gm injection is an anticancer and cytoprotective drug belonging to the category of alkylating agents and hemorrhagic cystitis inhibitors, containing the active ingredient Ifosfamide and Mesna. These drugs are indicated for the treatment of bladder inflammation and cancers in the soft tissues, germ cells, pancreas, and cervix. Mesna mainly protects against some of the harmful effects of certain chemotherapy medications. 

If you had an allergic reaction to this drug or any of its components, it should not be used. This medicine may cause severe bone marrow suppression which results in low white blood cell count or low platelet count due to chemotherapy or radiation therapy. You should wait for three months before starting the treatment with this drug if you have received a live virus vaccine such as measles, mumps, rubella, or chickenpox. It is advised to use this drug with caution in severe kidney or liver-diseased individuals. Talk to your doctor if you take any other medications or before using over-the-counter medicines or herbal products. Your doctor will evaluate the risk of interaction with this medication.

Consult your doctor before using this medication if you are pregnant or plan to have a baby. Ifex-M 2gm injection is unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this drug. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Breastfeeding should be avoided during the treatment with this drug as it may pass into breast milk in small amounts.

Uses of Ifex-m 2gm Injection

• Hemorrhagic cystitis (bladder inflammation)
• Soft tissue cancer
• Germ cell cancer
• Pancreatic cancer
• Cervical cancer

More Information

• Store Ifex-M 2gm injection in a refrigerator (20°C to 25°C).
• Do not freeze.
• Keep it out of reach from children.

Safety Advices  Pregnancy  

Ifex-M 2gm injection is unsafe for pregnant women as it may harm the unborn baby. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant.  

Breast Feeding  

Ifex-M 2gm injection is not recommended in breastfeeding women as it may pass into the breast milk.  

Lungs  

It is unknown whether Ifex-M 2gm injection can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

It is unknown whether Ifex-M 2gm injection can be used for patients with liver disorders. Consult your doctor if you have any liver diseases before starting the treatment.  

Alcohol  

It is unknown whether consuming alcohol interacts with the Ifex-M 2gm injection. Please consult your doctor for more advice.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking the Ifex-M 2gm injection.

Side Effects

• Immune system suppression
• Low levels of RBC, WBC, and platelets in the blood
• Bone marrow suppression
• Nerve toxicity
• Urinary problems
• Lung problems
• Kidney problem
• Rash
• Hypersensitivity reactions

• Hair loss
• Fever
• Phlebitis
• Liver toxicity
• Infections

Strength	2000 mg
Treatment Type	Breast Cancer
Dosage Form	Injection
Brand	Baxter
Dose	2 g
Packaging Type	Vial
Physical Form	Solution
Route of Administration	IV Infusion
Form	Injection
Manufacturer	Baxter
Storage Condition	Store Holoxan with uromitexan 2gm injection in a refrigerator (20 DegreeC to 25 DegreeC).
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Holoxan With Uromitexan 2gm injection is an anticancer and cytoprotective drug belonging to the category of alkylating agents and hemorrhagic cystitis inhibitors, containing the active ingredient Ifosfamide and Mesna. These drugs are indicated for the treatment of bladder inflammation and cancers in the soft tissues, germ cells, pancreas, and cervix. Mesna mainly protects against some of the harmful effects of certain chemotherapy medications. 

If you had an allergic reaction to this drug or any of its components, it should not be used. This medicine may cause severe bone marrow suppression which results in low white blood cell count or low platelet count due to chemotherapy or radiation therapy. You should wait for three months before starting the treatment with this drug if you have received a live virus vaccine such as measles, mumps, rubella, or chickenpox. It is advised to use this drug with caution in severe kidney or liver-diseased individuals. Talk to your doctor if you take any other medications or before using over-the-counter medicines or herbal products. Your doctor will evaluate the risk of interaction with this medication.

Consult your doctor before using this medication if you are pregnant or plan to have a baby. Holoxan With Uromitexan 2gm injection is unsafe to use during pregnancy as it causes harm to an unborn fetus. Your healthcare practitioner will conduct a pregnancy test before you start treatment with this drug. Discuss with your doctor effective birth control methods and utilize them for at least two weeks following the last dose. Breastfeeding should be avoided during the treatment with this drug as it may pass into breast milk in small amounts.

Uses of Holoxan With Uromitexan 2gm Injection

• Hemorrhagic cystitis (bladder inflammation)
• Soft tissue cancer
• Germ cell cancer
• Pancreatic cancer
• Cervical cancer

More Information

• Store Holoxan With Uromitexan 2gm injection in a refrigerator (20°C to 25°C).
• Do not freeze.
• Keep it out of reach from children.

Safety Advices Pregnancy  

Holoxan With Uromitexan 2gm injection is unsafe for pregnant women as it may harm the unborn baby. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant.  

Breast Feeding  

Holoxan With Uromitexan 2gm injection is not recommended in breastfeeding women as it may pass into the breast milk.  

Lungs  

It is unknown whether Holoxan With Uromitexan 2gm injection can be used for patients with lung problems. Consult your doctor if you have any lung diseases before starting the treatment.  

Liver  

It is unknown whether Holoxan With Uromitexan 2gm injection can be used for patients with liver disorders. Consult your doctor if you have any liver diseases before starting the treatment.  

Alcohol  

It is unknown whether consuming alcohol interacts with the Holoxan With Uromitexan 2gm injection. Please consult your doctor for more advice.  

Driving  

It is unsafe to drive vehicles or operate heavy machinery after taking the Holoxan With Uromitexan 2gm injection.

Side Effects

• Immune system suppression
• Low levels of RBC, WBC, and platelets in the blood
• Bone marrow suppression
• Nerve toxicity
• Urinary problems
• Lung problems
• Kidney problem
• Rash
• Hypersensitivity reactions

• Hair loss
• Fever
• Phlebitis
• Liver toxicity
• Infections